SNP	eGene	CHR	POS	SNP_PHENOTYPE	END	First_Level	PHENOTYPE	Metabolism	Locus	Locus name	Entrez Gene Name	Location	Type(s)	Most associated metabolite or ratio	Biochemical locus-metabolite relationship [PMID]	Predicted causal gene	eQTL (gene and tissue)	Complex trait association [PMID]	Metabolite association [PMID]	Inborn error metabolism	Gene/protein classification (DT=drug target, ME=metabolic enzyme, TP=transporter)	ChEMBL ID	Drug information	In development PharmaProjects (preclinical, Phase I to III, pre-registration, registration)	Failed PharmaProjects (Suspended, withdrawn, no development)	split_eQTLs	causal_eGene	split	Overlap
rs10022462	RP11-10L	4	89206094	2-aminobutyrate	89252573	Unknown		False	36	PPM1K	protein phosphatase, Mg2+/Mn2+ dependent, 1K	Cytoplasm	phosphatase	2-aminobutyrate	PPM1K encodes the phosphatase for the branched-chain keto acid dehydrogenase complex (BCKD) [19411760].  BCKD catalyzes an essential step in the catabolism of the valine and the other branched chain amino acids.	PPM1K	PPM1K-LIVER	NA	NA	NA	NA	NA	NA	NA	NA	PPM1K LIVER	True	PPM1K	False
rs10022462	HERC6	4	89299891	2-aminobutyrate	89364263	Unknown		False	36	PPM1K	protein phosphatase, Mg2+/Mn2+ dependent, 1K	Cytoplasm	phosphatase	2-aminobutyrate	PPM1K encodes the phosphatase for the branched-chain keto acid dehydrogenase complex (BCKD) [19411760].  BCKD catalyzes an essential step in the catabolism of the valine and the other branched chain amino acids.	PPM1K	PPM1K-LIVER	NA	NA	NA	NA	NA	NA	NA	NA	PPM1K LIVER	True	PPM1K	False
rs10022462	PPM1K	4	89178772	2-aminobutyrate	89205921	Unknown		False	36	PPM1K	protein phosphatase, Mg2+/Mn2+ dependent, 1K	Cytoplasm	phosphatase	2-aminobutyrate	PPM1K encodes the phosphatase for the branched-chain keto acid dehydrogenase complex (BCKD) [19411760].  BCKD catalyzes an essential step in the catabolism of the valine and the other branched chain amino acids.	PPM1K	PPM1K-LIVER	NA	NA	NA	NA	NA	NA	NA	NA	PPM1K LIVER	True	PPM1K	True
rs10022462	SNCA	4	90645250	2-aminobutyrate	90759411	Unknown		False	36	PPM1K	protein phosphatase, Mg2+/Mn2+ dependent, 1K	Cytoplasm	phosphatase	2-aminobutyrate	PPM1K encodes the phosphatase for the branched-chain keto acid dehydrogenase complex (BCKD) [19411760].  BCKD catalyzes an essential step in the catabolism of the valine and the other branched chain amino acids.	PPM1K	PPM1K-LIVER	NA	NA	NA	NA	NA	NA	NA	NA	PPM1K LIVER	True	PPM1K	False
rs1005390	TMEM176B	7	150488373	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	150498448	Unknown		False	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs1005390	TMEM176A	7	150497622	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	150502208	Unknown		False	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs1005390	SLC4A2	7	150754297	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	150772862	Organismal Systems		False	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs1005390	ATG9B	7	150709297	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	150721586	Cellular Processes		False	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs1005390	AOC1	7	150521715	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	150558592	Metabolism	Amino acid metabolism	True	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	True
rs1005390	MGAM	7	141607613	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	141806547	Metabolism, Organismal Systems	Carbohydrate metabolism	True	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs1005390	VIPR2	7	158822887	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	158937649	Environmental Information Processing		False	65	ABP1 (AOC1)	amiloride binding protein 1 (amine oxidase (copper-containing))	Extracellular Space	enzyme	4-acetamidobutanoate/ X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga).  X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.	ABP1 (AOC1)	KCNH2-LCL,REPIN1-LCL,TMEM176A-FAT	NA	NA	NA	ME	CHEMBL2118	No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL	NA	NA	KCNH2 LCL REPIN1 LCL TMEM176A FAT	False	ABP1  AOC1 	False
rs10112574	ADHFE1	8	67344718	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	67383675	Unknown		False	70	ADHFE1	alcohol dehydrogenase, iron containing, 1	Cytoplasm	enzyme	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	ADHFE1 encodes  the hydroxyacid-oxoacid transhydrogenase which catalyzes the oxidation of 4-hydroxybutanoic acid to 4-oxobutanoic acid, while reducing 2-oxoglutarate to 2-hydroxyglutarate [16616524]. X-05491 was identified as 2-hydroxyglutarate and its closest neighbor is X-04499 in the GGM.  X-04499 was identified as 3,4 dihydroxybutyrate. [23093944].  Ratio interpretation: n/a.	ADHFE1	ADHFE1-FAT,ADHFE1-LCL,C8orf46-FAT	NA	NA	NA	ME	CHEMBL4947	No specific drug is primarily metabolised by this enzyme; compounds with activity in ChEMBL	NA	NA	ADHFE1 FAT ADHFE1 LCL C8orf46 FAT	True	ADHFE1	True
rs10112574	C8orf46	8	67372238	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	67430759	Unknown		False	70	ADHFE1	alcohol dehydrogenase, iron containing, 1	Cytoplasm	enzyme	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	ADHFE1 encodes  the hydroxyacid-oxoacid transhydrogenase which catalyzes the oxidation of 4-hydroxybutanoic acid to 4-oxobutanoic acid, while reducing 2-oxoglutarate to 2-hydroxyglutarate [16616524]. X-05491 was identified as 2-hydroxyglutarate and its closest neighbor is X-04499 in the GGM.  X-04499 was identified as 3,4 dihydroxybutyrate. [23093944].  Ratio interpretation: n/a.	ADHFE1	ADHFE1-FAT,ADHFE1-LCL,C8orf46-FAT	NA	NA	NA	ME	CHEMBL4947	No specific drug is primarily metabolised by this enzyme; compounds with activity in ChEMBL	NA	NA	ADHFE1 FAT ADHFE1 LCL C8orf46 FAT	True	ADHFE1	False
rs10112574	MYBL1	8	67474410	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	67525529	Unknown		False	70	ADHFE1	alcohol dehydrogenase, iron containing, 1	Cytoplasm	enzyme	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	ADHFE1 encodes  the hydroxyacid-oxoacid transhydrogenase which catalyzes the oxidation of 4-hydroxybutanoic acid to 4-oxobutanoic acid, while reducing 2-oxoglutarate to 2-hydroxyglutarate [16616524]. X-05491 was identified as 2-hydroxyglutarate and its closest neighbor is X-04499 in the GGM.  X-04499 was identified as 3,4 dihydroxybutyrate. [23093944].  Ratio interpretation: n/a.	ADHFE1	ADHFE1-FAT,ADHFE1-LCL,C8orf46-FAT	NA	NA	NA	ME	CHEMBL4947	No specific drug is primarily metabolised by this enzyme; compounds with activity in ChEMBL	NA	NA	ADHFE1 FAT ADHFE1 LCL C8orf46 FAT	True	ADHFE1	False
rs10112574	FOXN3	14	89591215	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	90085493	Unknown		False	70	ADHFE1	alcohol dehydrogenase, iron containing, 1	Cytoplasm	enzyme	X-04499--3,4-dihydroxybutyrate/ C-glycosyltryptophan	ADHFE1 encodes  the hydroxyacid-oxoacid transhydrogenase which catalyzes the oxidation of 4-hydroxybutanoic acid to 4-oxobutanoic acid, while reducing 2-oxoglutarate to 2-hydroxyglutarate [16616524]. X-05491 was identified as 2-hydroxyglutarate and its closest neighbor is X-04499 in the GGM.  X-04499 was identified as 3,4 dihydroxybutyrate. [23093944].  Ratio interpretation: n/a.	ADHFE1	ADHFE1-FAT,ADHFE1-LCL,C8orf46-FAT	NA	NA	NA	ME	CHEMBL4947	No specific drug is primarily metabolised by this enzyme; compounds with activity in ChEMBL	NA	NA	ADHFE1 FAT ADHFE1 LCL C8orf46 FAT	True	ADHFE1	False
rs10211524	SLC1A4	2	65215611	2-aminobutyrate	65250999	Unknown		False	17	SLC1A4	solute carrier family 1 (glutamate/neutral amino acid transporter), member 4	Plasma Membrane	transporter	2-aminobutyrate	SLC1A4 encodes a neutral amino acid transporter with demonstrated activity for alanine, serine, cysteine and threonine [7896285].  2-aminobutyrate is structurally similar to these amino acids.	SLC1A4	NA	NA	Metabolite levels [22916037]	NA	NA	CHEMBL2315	Compounds with low inibitory activity in ChEMBL	NA	NA	NA	False	SLC1A4	True
rs10242455	TRIM4	7	99488036	X-12063	99517223	Unknown		False	61	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	X-12063	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids  [10403825].  X-12063 seems to be an unusual bile acid.	CYP3A5	CYP3A5-LIVER,CYP3A5-FAT,BUD31-LCL,TRIM4-Skin,ZNF394-LCL	NA	X-12063 [23093944]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CYP3A5 LIVER CYP3A5 FAT BUD31 LCL TRIM4 Skin ZNF394 LCL	True	CYP3A5	False
rs10242455	CYP3A5	7	99245817	X-12063	99277621	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	61	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	X-12063	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids  [10403825].  X-12063 seems to be an unusual bile acid.	CYP3A5	CYP3A5-LIVER,CYP3A5-FAT,BUD31-LCL,TRIM4-Skin,ZNF394-LCL	NA	X-12063 [23093944]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CYP3A5 LIVER CYP3A5 FAT BUD31 LCL TRIM4 Skin ZNF394 LCL	True	CYP3A5	True
rs10242455	ATP5J2	7	99046098	X-12063	99063954	Unknown		False	61	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	X-12063	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids  [10403825].  X-12063 seems to be an unusual bile acid.	CYP3A5	CYP3A5-LIVER,CYP3A5-FAT,BUD31-LCL,TRIM4-Skin,ZNF394-LCL	NA	X-12063 [23093944]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CYP3A5 LIVER CYP3A5 FAT BUD31 LCL TRIM4 Skin ZNF394 LCL	True	CYP3A5	False
rs10242455	ARPC1B	7	98971872	X-12063	98992424	Cellular Processes, Organismal Systems, Human Diseases		False	61	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	X-12063	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids  [10403825].  X-12063 seems to be an unusual bile acid.	CYP3A5	CYP3A5-LIVER,CYP3A5-FAT,BUD31-LCL,TRIM4-Skin,ZNF394-LCL	NA	X-12063 [23093944]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CYP3A5 LIVER CYP3A5 FAT BUD31 LCL TRIM4 Skin ZNF394 LCL	True	CYP3A5	False
rs10242455	CYP3A43	7	99425636	X-12063	99463718	Human Diseases		False	61	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	X-12063	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids  [10403825].  X-12063 seems to be an unusual bile acid.	CYP3A5	CYP3A5-LIVER,CYP3A5-FAT,BUD31-LCL,TRIM4-Skin,ZNF394-LCL	NA	X-12063 [23093944]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CYP3A5 LIVER CYP3A5 FAT BUD31 LCL TRIM4 Skin ZNF394 LCL	True	CYP3A5	False
rs1046080	LY6G5B	6	31637944	X-11444/ X-11470	31641553	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	HLA-DRB6	6	32520490	X-11444/ X-11470	32527799	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	LY6G5C	6	31644461	X-11444/ X-11470	31651817	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	NOTCH4	6	32162620	X-11444/ X-11470	32191844	Environmental Information Processing, Organismal Systems, Human Diseases		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	PSORS1C3	6	31141512	X-11444/ X-11470	31145676	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	ATF6B	6	32083112	X-11444/ X-11470	32096030	Genetic Information Processing, Environmental Information Processing, Organismal Systems, Human Diseases		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	SKIV2L	6	31926888	X-11444/ X-11470	31937532	Genetic Information Processing		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	HCG27	6	31165915	X-11444/ X-11470	31171745	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	PRRT1	6	32116136	X-11444/ X-11470	32121621	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	STK19	6	31938943	X-11444/ X-11470	31949228	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	HCG20	6	30734602	X-11444/ X-11470	30760027	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	BAG6	6	31606805	X-11444/ X-11470	31620482	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	MICB	6	31462658	X-11444/ X-11470	31478901	Organismal Systems		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	DDAH2	6	31694815	X-11444/ X-11470	31698357	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	LY6G6E	6	31679548	X-11444/ X-11470	31681842	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	DXO	6	31937587	X-11444/ X-11470	31940069	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	NELFE	6	31919864	X-11444/ X-11470	31926856	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	LINC00243	6	30766431	X-11444/ X-11470	30798436	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	VWA7	6	31733367	X-11444/ X-11470	31745108	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	PRRC2A	6	31588497	X-11444/ X-11470	31605548	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	HLA-DQB1	6	32627244	X-11444/ X-11470	32636160	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	NUDT3	6	34254546	X-11444/ X-11470	34360451	Unknown		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1046080	SIPA1L1	14	71787166	X-11444/ X-11470	72207946	Environmental Information Processing		False	50	PRRC2A	proline-rich coiled-coil 2A	Cytoplasm	other	X-11444/ X-11470	X-11470 is a GGM neighbor of cortisol [23093944]. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs10468017	ALDH1A2	15	58245622	1-palmitoylglycero-phosphoethanolamine	58790065	Metabolism	Metabolism of cofactors and vitamins	True	108	LIPC	solute carrier family 27 (fatty acid transporter), member 2	Cytoplasm	transporter	1-palmitoylglycero-phosphoethanolamine	LIPC encodes hepatic lipase with activity against both triacylglycerols and phospholipids [6511790].  Hydrolysis of phospholipids generates lysolipids and fatty acids.	LIPC	SLTM-LCL	Age-related macular degeneration [21665990,20385826]; Cardiovascular disease risk factors [21943158]; HDL cholesterol [19060906,18193043]; Metabolic syndrome (bivariate traits) [21386085]; Phospholipid levels (plasma) [22359512]; Triglycerides [18193043]	PE [19043545]; LPE 16:0 [23823483]	NA	NA	CHEMBL2127	Compounds with no activity in ChEMBL	NA	NA	SLTM LCL	False	LIPC	False
rs10468017	KIAA1467	12	13197218	1-palmitoylglycero-phosphoethanolamine	13295455	Unknown		False	108	LIPC	solute carrier family 27 (fatty acid transporter), member 2	Cytoplasm	transporter	1-palmitoylglycero-phosphoethanolamine	LIPC encodes hepatic lipase with activity against both triacylglycerols and phospholipids [6511790].  Hydrolysis of phospholipids generates lysolipids and fatty acids.	LIPC	SLTM-LCL	Age-related macular degeneration [21665990,20385826]; Cardiovascular disease risk factors [21943158]; HDL cholesterol [19060906,18193043]; Metabolic syndrome (bivariate traits) [21386085]; Phospholipid levels (plasma) [22359512]; Triglycerides [18193043]	PE [19043545]; LPE 16:0 [23823483]	NA	NA	CHEMBL2127	Compounds with no activity in ChEMBL	NA	NA	SLTM LCL	False	LIPC	False
rs10491431	RANBP3L	5	36248536	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	36302216	Unknown		False	41	UGT3A1	UDP glycosyltransferase 3 family, polypeptide A1	unknown	enzyme	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	UGT3A1 has activity against 17alpha-estradiol and 17beta-estradiol [18981171].  UGT3A2 has activity against estrogens [21088224]. X-11445 has been identified as 5-alpha-pregnan-3beta,20alpha-disulfate	UGT3A1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	UGT3A1	False
rs10491431	DAB2	5	39371780	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	39462402	Cellular Processes		False	41	UGT3A1	UDP glycosyltransferase 3 family, polypeptide A1	unknown	enzyme	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	UGT3A1 has activity against 17alpha-estradiol and 17beta-estradiol [18981171].  UGT3A2 has activity against estrogens [21088224]. X-11445 has been identified as 5-alpha-pregnan-3beta,20alpha-disulfate	UGT3A1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	UGT3A1	False
rs10504073	C8orf22	8	49966870	lysine/ glutaroyl carnitine	49988649	Unknown		False	69	SNAI2	snail homolog 2 (Drosophila)	Nucleus	transcription regulator	lysine/ glutaroyl carnitine	Glutaroyl carnitine is related to products of lysine degradation. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs10504073	EFCAB1	8	49623348	lysine/ glutaroyl carnitine	49647870	Unknown		False	69	SNAI2	snail homolog 2 (Drosophila)	Nucleus	transcription regulator	lysine/ glutaroyl carnitine	Glutaroyl carnitine is related to products of lysine degradation. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs10504073	RP11-10H	8	50081098	lysine/ glutaroyl carnitine	50141484	Unknown		False	69	SNAI2	snail homolog 2 (Drosophila)	Nucleus	transcription regulator	lysine/ glutaroyl carnitine	Glutaroyl carnitine is related to products of lysine degradation. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	CCDC163P	1	45959538	erythritol	45965724	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	MMACHC	1	45965752	erythritol	45976707	Organismal Systems		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	TMEM69	1	46152886	erythritol	46159995	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	PRDX1	1	45976740	erythritol	45988719	Cellular Processes		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	MAST2	1	46252659	erythritol	46501796	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	PIK3R3	1	46505812	erythritol	46642160	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	NSUN4	1	46805849	erythritol	46830824	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	ERI3	1	44686742	erythritol	44820932	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1053941	SZRD1	1	16679070	erythritol	16724640	Unknown		False	2	NASP	nuclear autoantigenic sperm protein (histone-binding)	Nucleus	other	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11101730	FUOM	10	135168658	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	135171529	Unknown		False	86	PAOX	polyamine oxidase (exo-N4-amino)	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	ME	CHEMBL2105	No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL	NA	NA	NA	False	unknown	False
rs11101730	PAOX	10	135192695	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	135205198	Cellular Processes		False	86	PAOX	polyamine oxidase (exo-N4-amino)	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	ME	CHEMBL2105	No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL	NA	NA	NA	False	unknown	False
rs11101730	ECHS1	10	135175984	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	135187193	Metabolism	Amino acid metabolism	True	86	PAOX	polyamine oxidase (exo-N4-amino)	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	ME	CHEMBL2105	No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1163251	ZNF697	1	120162045	Serine	120190396	Unknown		False	10	PHGDH	phosphoglycerate dehydrogenase	Cytoplasm	enzyme	Serine	PHGDH encodes a phosphoglycerate dehydrogenase which catalyses the first and rate‐limiting step in serine biosynthesis [16589713].	PHGDH	PHGDH-FAT,PHGDH-Skin,NOTCH2-LCL	NA	serine [21886157] (r2=0.477 with rs477992); Ornithine/Serine [20037589];  Serine [23823483]	3-Phosphoglycerate dehydrogenase deficiency	NA	NA	NA	NA	NA	PHGDH FAT PHGDH Skin NOTCH2 LCL	True	PHGDH	False
rs1163251	PHGDH	1	120202421	Serine	120286838	Metabolism	Amino acid metabolism	True	10	PHGDH	phosphoglycerate dehydrogenase	Cytoplasm	enzyme	Serine	PHGDH encodes a phosphoglycerate dehydrogenase which catalyses the first and rate‐limiting step in serine biosynthesis [16589713].	PHGDH	PHGDH-FAT,PHGDH-Skin,NOTCH2-LCL	NA	serine [21886157] (r2=0.477 with rs477992); Ornithine/Serine [20037589];  Serine [23823483]	3-Phosphoglycerate dehydrogenase deficiency	NA	NA	NA	NA	NA	PHGDH FAT PHGDH Skin NOTCH2 LCL	True	PHGDH	True
rs1163251	MACF1	1	39546988	Serine	39952849	Unknown		False	10	PHGDH	phosphoglycerate dehydrogenase	Cytoplasm	enzyme	Serine	PHGDH encodes a phosphoglycerate dehydrogenase which catalyses the first and rate‐limiting step in serine biosynthesis [16589713].	PHGDH	PHGDH-FAT,PHGDH-Skin,NOTCH2-LCL	NA	serine [21886157] (r2=0.477 with rs477992); Ornithine/Serine [20037589];  Serine [23823483]	3-Phosphoglycerate dehydrogenase deficiency	NA	NA	NA	NA	NA	PHGDH FAT PHGDH Skin NOTCH2 LCL	True	PHGDH	False
rs11647589	ACSM5	16	20420856	3-phenylpropionate (hydrocinnamate)	20452571	Metabolism	Carbohydrate metabolism	True	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	RP11-143	16	20598007	3-phenylpropionate (hydrocinnamate)	20618429	Unknown		False	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	AC004381.6	16	20817999	3-phenylpropionate (hydrocinnamate)	20860987	Unknown		False	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	ACSM1	16	20634559	3-phenylpropionate (hydrocinnamate)	20710212	Metabolism	Carbohydrate metabolism	True	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	ACSM3	16	20621565	3-phenylpropionate (hydrocinnamate)	20807446	Metabolism	Carbohydrate metabolism	True	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	PDILT	16	20370492	3-phenylpropionate (hydrocinnamate)	20416059	Unknown		False	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	EEF2K	16	22217603	3-phenylpropionate (hydrocinnamate)	22298554	Environmental Information Processing, Organismal Systems		False	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs11647589	TPT1-AS1	13	45915506	3-phenylpropionate (hydrocinnamate)	45965857	Unknown		False	116	ACSM5	acyl-CoA synthetase medium-chain family member 5	unknown	enzyme	3-phenylpropionate (hydrocinnamate)	3-phenylpropionate is derived from phenylalanine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1171615	SLC16A9	10	61410523	carnitine/ X-12798	61495760	Unknown		False	78	SLC16A9	solute carrier family 16, member 9 (monocarboxylic acid transporter 9)	unknown	other	carnitine/ X-12798	SLC16A9 encodes a carnitine efflux transporter [21886157]. Ratio interpretation: n/a.	SLC16A9	SLC16A9-LCL	Urate levels [23263486]; Uric Acid [19503597]	Carnitine [21886157] (r2=0.346 with rs7094971); C0 [20037589] (r2=0.346 with rs7094971); Carnitine [23823483]	NA	NA	NA	NA	NA	NA	SLC16A9 LCL	True	SLC16A9	True
rs1171615	CCDC6	10	61548521	carnitine/ X-12798	61666414	Human Diseases		False	78	SLC16A9	solute carrier family 16, member 9 (monocarboxylic acid transporter 9)	unknown	other	carnitine/ X-12798	SLC16A9 encodes a carnitine efflux transporter [21886157]. Ratio interpretation: n/a.	SLC16A9	SLC16A9-LCL	Urate levels [23263486]; Uric Acid [19503597]	Carnitine [21886157] (r2=0.346 with rs7094971); C0 [20037589] (r2=0.346 with rs7094971); Carnitine [23823483]	NA	NA	NA	NA	NA	NA	SLC16A9 LCL	True	SLC16A9	False
rs1185567	SLC17A1	6	25783125	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	25832287	Unknown		False	49	SLC17A3	solute carrier family 17 (sodium phosphate), member 3	Plasma Membrane	transporter	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	dehydroisoandrosterone sulfate (DHEA-S) and 4-androsten-3beta,17beta-diol disulfate 2 are steroid hormones. Ratio interpretation: n/a.	unknown	NA	Cardiovascular disease risk factors [21943158]; Urate levels [18834626,23263486,20884846]; Uric acid levels [19503597]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1185567	SLC17A3	6	25833294	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	25874471	Unknown		False	49	SLC17A3	solute carrier family 17 (sodium phosphate), member 3	Plasma Membrane	transporter	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	dehydroisoandrosterone sulfate (DHEA-S) and 4-androsten-3beta,17beta-diol disulfate 2 are steroid hormones. Ratio interpretation: n/a.	unknown	NA	Cardiovascular disease risk factors [21943158]; Urate levels [18834626,23263486,20884846]; Uric acid levels [19503597]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1185567	U91328.19	6	25992890	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	26002003	Unknown		False	49	SLC17A3	solute carrier family 17 (sodium phosphate), member 3	Plasma Membrane	transporter	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	dehydroisoandrosterone sulfate (DHEA-S) and 4-androsten-3beta,17beta-diol disulfate 2 are steroid hormones. Ratio interpretation: n/a.	unknown	NA	Cardiovascular disease risk factors [21943158]; Urate levels [18834626,23263486,20884846]; Uric acid levels [19503597]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1185567	TRIM38	6	25963030	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	25987384	Unknown		False	49	SLC17A3	solute carrier family 17 (sodium phosphate), member 3	Plasma Membrane	transporter	dehydroisoandrosterone sulfate (DHEA-S)/ 4-androsten-3beta,17beta-diol disulfate 2	dehydroisoandrosterone sulfate (DHEA-S) and 4-androsten-3beta,17beta-diol disulfate 2 are steroid hormones. Ratio interpretation: n/a.	unknown	NA	Cardiovascular disease risk factors [21943158]; Urate levels [18834626,23263486,20884846]; Uric acid levels [19503597]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12141041	DOCK3	3	50712672	Alpha-hydroxyisovalerate	51421629	Unknown		False	9	HAO2	hydroxyacid oxidase 2 (long chain)	Cytoplasm	enzyme	Alpha-hydroxyisovalerate	HAO2 encodes a 2-hydroxyacid oxidase which catalyzes the oxidation of L-alpha-hydroxy acids; alpha-hydroxyisovalerate or a related metabolite may be a potential substrate [10777549].	HAO2	NA	NA	NA	NA	NA	CHEMBL2021745	Compounds with low inhibitory activity in ChEMBL	NA	1	NA	False	HAO2	False
rs12141041	CD2	1	117297007	Alpha-hydroxyisovalerate	117311850	Environmental Information Processing, Organismal Systems		False	9	HAO2	hydroxyacid oxidase 2 (long chain)	Cytoplasm	enzyme	Alpha-hydroxyisovalerate	HAO2 encodes a 2-hydroxyacid oxidase which catalyzes the oxidation of L-alpha-hydroxy acids; alpha-hydroxyisovalerate or a related metabolite may be a potential substrate [10777549].	HAO2	NA	NA	NA	NA	NA	CHEMBL2021745	Compounds with low inhibitory activity in ChEMBL	NA	1	NA	False	HAO2	False
rs12141041	MAN1A2	1	117910071	Alpha-hydroxyisovalerate	118071494	Metabolism, Genetic Information Processing	Carbohydrate metabolism	True	9	HAO2	hydroxyacid oxidase 2 (long chain)	Cytoplasm	enzyme	Alpha-hydroxyisovalerate	HAO2 encodes a 2-hydroxyacid oxidase which catalyzes the oxidation of L-alpha-hydroxy acids; alpha-hydroxyisovalerate or a related metabolite may be a potential substrate [10777549].	HAO2	NA	NA	NA	NA	NA	CHEMBL2021745	Compounds with low inhibitory activity in ChEMBL	NA	1	NA	False	HAO2	False
rs12550729	MAF1	8	145159402	5-oxoproline	145162514	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	PARP10	8	145051321	5-oxoproline	145086940	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	KIAA1875	8	145162629	5-oxoproline	145173218	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	GPAA1	8	145137493	5-oxoproline	145141119	Metabolism	Carbohydrate metabolism	True	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	SHARPIN	8	145153536	5-oxoproline	145162961	Cellular Processes, Organismal Systems		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	EXOSC4	8	145134326	5-oxoproline	145135550	Genetic Information Processing		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	OPLAH	8	145106630	5-oxoproline	145118735	Metabolism	Amino acid metabolism	True	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	True
rs12550729	CTD-3065	8	145132905	5-oxoproline	145134168	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	EPPK1	8	144939497	5-oxoproline	144952632	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12550729	PLEC	8	144989321	5-oxoproline	145050902	Unknown		False	71	OPLAH	5-oxoprolinase (ATP-hydrolysing)	Cytoplasm	enzyme	5-oxoproline	OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent hydrolysis of 5-oxoproline to glutamic acid [9233839]	OPLAH	NA	NA	5-oxoproline [21886157]	NA	NA	NA	NA	NA	NA	NA	False	OPLAH	False
rs12602901	RP11-81A	17	4704454	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4710308	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	ENO3	17	4851387	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4860426	Metabolism, Genetic Information Processing, Environmental Information Processing	Carbohydrate metabolism	True	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	INCA1	17	4891521	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4900905	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	CAMTA2	17	4871287	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4890939	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	RNF167	17	4843547	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4848517	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	SPAG7	17	4862521	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4871167	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	GP1BA	17	4835592	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4838325	Environmental Information Processing, Organismal Systems		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	C17orf107	17	4802713	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4806227	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	C1QBP	17	5336197	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	5352128	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	SLC25A11	17	4840425	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4843302	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	SLC52A1	17	4935895	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4955304	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs12602901	KIF1C	17	4901243	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	4931696	Unknown		False	125	RNF167	ring finger protein 167	Cytoplasm	enzyme	X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1260326	AC074117	2	27579360	glucose/ mannose	27590489	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	NRBP1	2	27650657	glucose/ mannose	27665126	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	KRTCAP3	2	27665233	glucose/ mannose	27669348	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	ZNF513	2	27600098	glucose/ mannose	27603657	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	ATRAID	2	27435155	glucose/ mannose	27440046	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	PPM1G	2	27604061	glucose/ mannose	27632554	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	SNX17	2	27593389	glucose/ mannose	27599995	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	FNDC4	2	27714750	glucose/ mannose	27718112	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	False
rs1260326	GCKR	2	27719709	glucose/ mannose	27746554	Unknown		False	15	GCKR	glucokinase (hexokinase 4) regulator	Nucleus	other	glucose/ mannose	GCKR encodes the glucokinase regulatory protein which inhibits the glucokinase enzyme.  A common missense mutation in GCKR is associated with decreased glucose and increased triglycerides [18678614] .Ratio interpretation: unclear. GCKR influences glucose levels, but in this study the stronger association is with mannose	GCKR	EIF2B4-LCL	Breast size [22747683]; C-reactive protein [21300955,18439548]; Calcium levels [20705733]; Cardiovascular disease risk factors [21943158]; Cholesterol, total [20686565]; Chronic kidney disease [20383146]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; Fasting insulin-related traits [20081858]; Fasting insulin-related traits (interaction with BMI) [22581228]; Hypertriglyceridemia [20657596]; LDL cholesterol [18179892]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Metabolic syndrome [22399527]; Non-albumin protein levels [22558069]; Platelet counts [22139419]; Serum albumin level [23022100]; Serum total protein level [23022100]; Sex hormone-binding globulin levels [22829776]; Triglycerides [19060906,18193044,18193043,19060911,20864672,20686565]; Triglycerides-Blood Pressure (TG-BP) [21386085]; Two-hour glucose challenge [20081857]; Urate levels [20884846,23263486]; Uric acid levels [19503597]; Waist Circumference - Triglycerides (WC-TG) [21386085]; Waist circumference and related phenotypes [18454146]	Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [21829377]; Glucose/mannose [21886157]; Ala, Gln [22286219]	NA	NA	CHEMBL1075152	Compounds with activity in ChEMBL	NA	NA	EIF2B4 LCL	False	GCKR	True
rs12709013	GOT2	16	58741035	phenyllactate (PLA)/ phenylalanine	58768261	Metabolism, Organismal Systems	Amino acid metabolism	True	122	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)/ phenylalanine	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate. Ratio interpretation: phenylalanine is a substrate of GOT2, and PLA is derived from its product ('activity')	GOT2	GOT2-FAT,GOT2-LCL,GOT2-Skin	NA	NA	NA	NA	NA	NA	NA	NA	GOT2 FAT GOT2 LCL GOT2 Skin	True	GOT2	True
rs12709013	SLC38A7	16	58699013	phenyllactate (PLA)/ phenylalanine	58719008	Unknown		False	122	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)/ phenylalanine	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate. Ratio interpretation: phenylalanine is a substrate of GOT2, and PLA is derived from its product ('activity')	GOT2	GOT2-FAT,GOT2-LCL,GOT2-Skin	NA	NA	NA	NA	NA	NA	NA	NA	GOT2 FAT GOT2 LCL GOT2 Skin	True	GOT2	False
rs12709013	GEMIN8P2	16	58810444	phenyllactate (PLA)/ phenylalanine	58811467	Unknown		False	122	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)/ phenylalanine	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate. Ratio interpretation: phenylalanine is a substrate of GOT2, and PLA is derived from its product ('activity')	GOT2	GOT2-FAT,GOT2-LCL,GOT2-Skin	NA	NA	NA	NA	NA	NA	NA	NA	GOT2 FAT GOT2 LCL GOT2 Skin	True	GOT2	False
rs12709013	RP11-410	16	58767816	phenyllactate (PLA)/ phenylalanine	59142878	Unknown		False	122	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)/ phenylalanine	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate. Ratio interpretation: phenylalanine is a substrate of GOT2, and PLA is derived from its product ('activity')	GOT2	GOT2-FAT,GOT2-LCL,GOT2-Skin	NA	NA	NA	NA	NA	NA	NA	NA	GOT2 FAT GOT2 LCL GOT2 Skin	True	GOT2	False
rs13122250	TDO2	4	156775890	tryptophan	156841558	Metabolism	Amino acid metabolism	True	37	TDO2	tryptophan 2,3-dioxygenase	Cytoplasm	enzyme	tryptophan	TDO2 encodes tryptophan 2,3-dioxygenase which acts on tryptophan [8666386]	TDO2	NA	NA	NA	NA	NA	CHEMBL2140	Compounds with low inhibitory activity in ChEMBL	NA	NA	NA	False	TDO2	True
rs131794	SCO2	22	50961997	uridine	50964035	Human Diseases		False	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	False
rs131794	TYMP	22	50964181	uridine	50968485	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	True
rs131794	CHKB	22	51017378	uridine	51039884	Metabolism, Human Diseases	Lipid metabolism	True	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	False
rs131794	ODF3B	22	50968838	uridine	50971009	Unknown		False	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	False
rs131794	CPT1B	22	51007290	uridine	51017096	Metabolism, Environmental Information Processing, Organismal Systems, Human Diseases	Lipid metabolism	True	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	False
rs131794	CTA-384D	22	50962854	uridine	50963209	Unknown		False	144	TYMP	thymidine phosphorylase	Extracellular Space	growth factor	uridine	TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis of thymidine and deoxyuridine [7284378].  These pyrimidines are metabolically linked to uridine.	TYMP	SCO2-LCL	Mean corpuscular volume [19862010]	NA	Mitochondrial neurogastrointestinal encephalomyopathy	NA	CHEMBL3106	Compounds with activity in ChEMBL	2	NA	SCO2 LCL	False	TYMP	False
rs13222543	DIP2B	12	50898890	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	51142450	Unknown		False	62	ZCWPW1	zinc finger, CW type with PWWP domain 1	unknown	other	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	Androsterone sulfate is a steroid hormone. Ratio interpretation: substrate/Product pair ('activity').	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs13222543	ANKIB1	7	91875548	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	92030698	Unknown		False	62	ZCWPW1	zinc finger, CW type with PWWP domain 1	unknown	other	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	Androsterone sulfate is a steroid hormone. Ratio interpretation: substrate/Product pair ('activity').	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs13278849	ADRA1A	8	26605667	levulinate (4-oxovalerate)	26724790	Environmental Information Processing, Organismal Systems		False	67	ADRA1A	adrenoceptor alpha 1A	Plasma Membrane	G-protein coupled receptor	levulinate (4-oxovalerate)	NA	unknown	NA	NA	NA	NA	DT	CHEMBL229	Dopamine, Doxazosin, Epinephrine, Labetalol, Metaraminol, Methoxamine, Midodrine, Norepinephrine, Phenoxybenzamine, Phentolamine, Phenylpropanolamine, Prazosin, Pseudoephedrine, Tolazoline, Dapripazole, Dipivrefin, Naphazoline, Oxymetazoline, Phenylephrine, Tetrahydrozoline, among others	7	64	NA	False	unknown	False
rs13278849	COX6B1P4	8	26693334	levulinate (4-oxovalerate)	26693817	Unknown		False	67	ADRA1A	adrenoceptor alpha 1A	Plasma Membrane	G-protein coupled receptor	levulinate (4-oxovalerate)	NA	unknown	NA	NA	NA	NA	DT	CHEMBL229	Dopamine, Doxazosin, Epinephrine, Labetalol, Metaraminol, Methoxamine, Midodrine, Norepinephrine, Phenoxybenzamine, Phentolamine, Phenylpropanolamine, Prazosin, Pseudoephedrine, Tolazoline, Dapripazole, Dipivrefin, Naphazoline, Oxymetazoline, Phenylephrine, Tetrahydrozoline, among others	7	64	NA	False	unknown	False
rs13278849	RP11-150	8	37278859	levulinate (4-oxovalerate)	37411701	Unknown		False	67	ADRA1A	adrenoceptor alpha 1A	Plasma Membrane	G-protein coupled receptor	levulinate (4-oxovalerate)	NA	unknown	NA	NA	NA	NA	DT	CHEMBL229	Dopamine, Doxazosin, Epinephrine, Labetalol, Metaraminol, Methoxamine, Midodrine, Norepinephrine, Phenoxybenzamine, Phentolamine, Phenylpropanolamine, Prazosin, Pseudoephedrine, Tolazoline, Dapripazole, Dipivrefin, Naphazoline, Oxymetazoline, Phenylephrine, Tetrahydrozoline, among others	7	64	NA	False	unknown	False
rs13278849	MSR1	8	15965387	levulinate (4-oxovalerate)	16424999	Cellular Processes		False	67	ADRA1A	adrenoceptor alpha 1A	Plasma Membrane	G-protein coupled receptor	levulinate (4-oxovalerate)	NA	unknown	NA	NA	NA	NA	DT	CHEMBL229	Dopamine, Doxazosin, Epinephrine, Labetalol, Metaraminol, Methoxamine, Midodrine, Norepinephrine, Phenoxybenzamine, Phentolamine, Phenylpropanolamine, Prazosin, Pseudoephedrine, Tolazoline, Dapripazole, Dipivrefin, Naphazoline, Oxymetazoline, Phenylephrine, Tetrahydrozoline, among others	7	64	NA	False	unknown	False
rs13375749	C1orf123	1	53679870	glutaroyl carnitine	53686289	Unknown		False	5	CPT2	carnitine palmitoyltransferase 2	Cytoplasm	enzyme	glutaroyl carnitine	CPT2 encodes carnitine palmitoyltransferase II which catalyzes the transfer of palmitate and related metabolites from carnitine to coenzyme A in the mitochondrial inner membrane [9654057].	CPT2	NA	NA	NA	Carnitine palmitoyltransferase II (CPT II) deficiency	NA	CHEMBL3238	Compounds with inhibitory activity in ChEMBL	1	1	NA	False	CPT2	False
rs13375749	CPT2	1	53662101	glutaroyl carnitine	53679770	Metabolism, Organismal Systems	Lipid metabolism	True	5	CPT2	carnitine palmitoyltransferase 2	Cytoplasm	enzyme	glutaroyl carnitine	CPT2 encodes carnitine palmitoyltransferase II which catalyzes the transfer of palmitate and related metabolites from carnitine to coenzyme A in the mitochondrial inner membrane [9654057].	CPT2	NA	NA	NA	Carnitine palmitoyltransferase II (CPT II) deficiency	NA	CHEMBL3238	Compounds with inhibitory activity in ChEMBL	1	1	NA	False	CPT2	True
rs13375749	TSPAN1	1	46640745	glutaroyl carnitine	46651630	Unknown		False	5	CPT2	carnitine palmitoyltransferase 2	Cytoplasm	enzyme	glutaroyl carnitine	CPT2 encodes carnitine palmitoyltransferase II which catalyzes the transfer of palmitate and related metabolites from carnitine to coenzyme A in the mitochondrial inner membrane [9654057].	CPT2	NA	NA	NA	Carnitine palmitoyltransferase II (CPT II) deficiency	NA	CHEMBL3238	Compounds with inhibitory activity in ChEMBL	1	1	NA	False	CPT2	False
rs13538	ALMS1P	2	73872046	N-acetylornithine/ myo-inositol	73912703	Unknown		False	18	NAT8	N-acetyltransferase 8 (GCN5-related, putative)	Nucleus	transcription regulator	N-acetylornithine/ myo-inositol	NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity').  Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894]	NAT8	ALMS1-LCL,ALMS1-Skin	Chronic kidney disease [20383146]; Creatinine levels [20383145];	N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564];	NA	NA	NA	NA	NA	NA	ALMS1 LCL ALMS1 Skin	False	NAT8	False
rs13538	NAT8	2	73867959	N-acetylornithine/ myo-inositol	73869520	Unknown		False	18	NAT8	N-acetyltransferase 8 (GCN5-related, putative)	Nucleus	transcription regulator	N-acetylornithine/ myo-inositol	NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity').  Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894]	NAT8	ALMS1-LCL,ALMS1-Skin	Chronic kidney disease [20383146]; Creatinine levels [20383145];	N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564];	NA	NA	NA	NA	NA	NA	ALMS1 LCL ALMS1 Skin	False	NAT8	True
rs13538	TPRKB	2	73956231	N-acetylornithine/ myo-inositol	73964527	Unknown		False	18	NAT8	N-acetyltransferase 8 (GCN5-related, putative)	Nucleus	transcription regulator	N-acetylornithine/ myo-inositol	NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity').  Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894]	NAT8	ALMS1-LCL,ALMS1-Skin	Chronic kidney disease [20383146]; Creatinine levels [20383145];	N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564];	NA	NA	NA	NA	NA	NA	ALMS1 LCL ALMS1 Skin	False	NAT8	False
rs13538	ALMS1	2	73612886	N-acetylornithine/ myo-inositol	73837920	Unknown		False	18	NAT8	N-acetyltransferase 8 (GCN5-related, putative)	Nucleus	transcription regulator	N-acetylornithine/ myo-inositol	NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity').  Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894]	NAT8	ALMS1-LCL,ALMS1-Skin	Chronic kidney disease [20383146]; Creatinine levels [20383145];	N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564];	NA	NA	NA	NA	NA	NA	ALMS1 LCL ALMS1 Skin	False	NAT8	False
rs13538	AC104135.3	2	75145275	N-acetylornithine/ myo-inositol	75165545	Unknown		False	18	NAT8	N-acetyltransferase 8 (GCN5-related, putative)	Nucleus	transcription regulator	N-acetylornithine/ myo-inositol	NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity').  Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894]	NAT8	ALMS1-LCL,ALMS1-Skin	Chronic kidney disease [20383146]; Creatinine levels [20383145];	N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564];	NA	NA	NA	NA	NA	NA	ALMS1 LCL ALMS1 Skin	False	NAT8	False
rs1365505	SLC27A2	15	50474393	10-undecenoate (11:1n1)/ X-11438	50528592	Cellular Processes, Organismal Systems, Human Diseases		False	107	SLC27A2	isovaleryl-CoA dehydrogenase	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates fatty acids by forming their coenzyme A derivatives [10198260]. Ratio interpretation: n/a.	SLC27A2	NA	NA	NA	NA	NA	CHEMBL4326	Compounds with activity in ChEMBL	NA	NA	NA	False	SLC27A2	True
rs1365505	ATP8B4	15	50150435	10-undecenoate (11:1n1)/ X-11438	50411654	Unknown		False	107	SLC27A2	isovaleryl-CoA dehydrogenase	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates fatty acids by forming their coenzyme A derivatives [10198260]. Ratio interpretation: n/a.	SLC27A2	NA	NA	NA	NA	NA	CHEMBL4326	Compounds with activity in ChEMBL	NA	NA	NA	False	SLC27A2	False
rs1365505	GABPB1-AS1	15	50647606	10-undecenoate (11:1n1)/ X-11438	50659636	Unknown		False	107	SLC27A2	isovaleryl-CoA dehydrogenase	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates fatty acids by forming their coenzyme A derivatives [10198260]. Ratio interpretation: n/a.	SLC27A2	NA	NA	NA	NA	NA	CHEMBL4326	Compounds with activity in ChEMBL	NA	NA	NA	False	SLC27A2	False
rs1365505	LIPC	15	58702768	10-undecenoate (11:1n1)/ X-11438	58861151	Metabolism, Organismal Systems	Lipid metabolism	True	107	SLC27A2	isovaleryl-CoA dehydrogenase	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates fatty acids by forming their coenzyme A derivatives [10198260]. Ratio interpretation: n/a.	SLC27A2	NA	NA	NA	NA	NA	CHEMBL4326	Compounds with activity in ChEMBL	NA	NA	NA	False	SLC27A2	False
rs1394678	ACSM5	16	20420856	indolepropionate	20452571	Metabolism	Carbohydrate metabolism	True	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	RP11-143	16	20598007	indolepropionate	20618429	Unknown		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	ACSM3	16	20621565	indolepropionate	20807446	Metabolism	Carbohydrate metabolism	True	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	THUMPD1	16	20744986	indolepropionate	20753406	Unknown		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	ACSM1	16	20634559	indolepropionate	20710212	Metabolism	Carbohydrate metabolism	True	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	AC004381.6	16	20817999	indolepropionate	20860987	Unknown		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	TMEM159	16	21169698	indolepropionate	21191937	Unknown		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	PDILT	16	20370492	indolepropionate	20416059	Unknown		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	PALB2	16	23614488	indolepropionate	23652631	Genetic Information Processing		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1394678	EEF2K	16	22217603	indolepropionate	22298554	Environmental Information Processing, Organismal Systems		False	118	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	indolepropionate	indolepropionate is derived from tryptophan metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1395	AC074117	2	27579360	pantothenate	27590489	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	ATRAID	2	27435155	pantothenate	27440046	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	NRBP1	2	27650657	pantothenate	27665126	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	KRTCAP3	2	27665233	pantothenate	27669348	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	SLC5A6	2	27422455	pantothenate	27435733	Organismal Systems		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	True
rs1395	SNX17	2	27593389	pantothenate	27599995	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	TRIM54	2	27505260	pantothenate	27530267	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	CAD	2	27440258	pantothenate	27466811	Metabolism	Amino acid metabolism	True	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	ANXA4	2	69871557	pantothenate	70053596	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	PAK2	3	196466728	pantothenate	196559518	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1395	VPS54	2	64119280	pantothenate	64246206	Unknown		False	14	SLC5A6	solute carrier family 5 (sodium-dependent vitamin transporter), member 6	Plasma Membrane	transporter	pantothenate	SLC5A6 is a pantothenate transporter [9516450]	SLC5A6	SLC5A6-FAT,SLC5A6-LCL,AGBL5-Skin,EIF2B4-Skin,GTF3C2-Skin,KHK-FAT,PREB-FAT	NA	Alanine [23823483]	NA	TP	NA	No specific drug is associated with this transporter	NA	NA	SLC5A6 FAT SLC5A6 LCL AGBL5 Skin EIF2B4 Skin GTF3C2 Skin KHK FAT PREB FAT	True	SLC5A6	False
rs1466788	STRIP1	1	110574199	Carnitine	110597263	Unknown		False	8	ALX3	ALX homeobox 3	Nucleus	transcription regulator	Carnitine	Carnitine is a quaternary ammonium compound required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (fats) for the generation of metabolic energy	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1466788	CCBL2	1	89401456	Carnitine	89454038	Unknown		False	8	ALX3	ALX homeobox 3	Nucleus	transcription regulator	Carnitine	Carnitine is a quaternary ammonium compound required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (fats) for the generation of metabolic energy	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs1472631	LACTB	15	63413999	succinylcarnitine	63434260	Unknown		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	RPS27L	15	63418071	succinylcarnitine	63450220	Genetic Information Processing		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	TPM1	15	63334831	succinylcarnitine	63364114	Organismal Systems, Human Diseases		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	RP11-321	15	63682335	succinylcarnitine	63729347	Unknown		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	APH1B	15	63568217	succinylcarnitine	63601325	Environmental Information Processing		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	RAB8B	15	63481668	succinylcarnitine	63559981	Cellular Processes		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	CEP152	15	49005125	succinylcarnitine	49102791	Unknown		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1472631	KIAA0101	15	64657193	succinylcarnitine	64679886	Unknown		False	110	LACTB	lactamase, beta	Cytoplasm	other	succinylcarnitine	Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate.  LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941].	unknown	NA	NA	succinylcarnitine [21886157]	NA	NA	CHEMBL3791	Compounds and one approved drug (Tazobactam) with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs1498694	PAH	12	103230663	phenylalanine	103344646	Metabolism	Metabolism of cofactors and vitamins	True	97	PAH	glutaminase 2 (liver, mitochondrial)	Cytoplasm	enzyme	phenylalanine	PAH encodes the enzyme phenylalanine hydroxylase which is the rate-limiting step in phenylalanine catabolism [4150152]	PAH	NA	NA	NA	Phenylketonuria (PKU)	DT	CHEMBL3076	Sapropterin	NA	2	NA	False	PAH	True
rs1498694	TDG	12	104359582	phenylalanine	104382652	Genetic Information Processing		False	97	PAH	glutaminase 2 (liver, mitochondrial)	Cytoplasm	enzyme	phenylalanine	PAH encodes the enzyme phenylalanine hydroxylase which is the rate-limiting step in phenylalanine catabolism [4150152]	PAH	NA	NA	NA	Phenylketonuria (PKU)	DT	CHEMBL3076	Sapropterin	NA	2	NA	False	PAH	False
rs1498694	RP11-611	12	70297813	phenylalanine	70636673	Unknown		False	97	PAH	glutaminase 2 (liver, mitochondrial)	Cytoplasm	enzyme	phenylalanine	PAH encodes the enzyme phenylalanine hydroxylase which is the rate-limiting step in phenylalanine catabolism [4150152]	PAH	NA	NA	NA	Phenylketonuria (PKU)	DT	CHEMBL3076	Sapropterin	NA	2	NA	False	PAH	False
rs1509123	FBXO39	17	6679542	citrate	6700420	Unknown		False	127	SLC13A5	solute carrier family 13 (sodium-dependent citrate transporter), member 5	Plasma Membrane	transporter	citrate	SLC13A5 encodes NaCT, a sodium-coupled citrate transporter [16973915]	SLC13A5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	SLC13A5	False
rs1509123	TEKT1	17	6692452	citrate	6735080	Unknown		False	127	SLC13A5	solute carrier family 13 (sodium-dependent citrate transporter), member 5	Plasma Membrane	transporter	citrate	SLC13A5 encodes NaCT, a sodium-coupled citrate transporter [16973915]	SLC13A5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	SLC13A5	False
rs15676	C9orf114	9	131581930	indolelactate	131592100	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	ENDOG	9	131580753	indolelactate	131581464	Cellular Processes		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	TBC1D13	9	131549483	indolelactate	131572711	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	PHYHD1	9	131683174	indolelactate	131704320	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	PKN3	9	131464802	indolelactate	131483147	Environmental Information Processing, Human Diseases		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	LRRC8A	9	131644391	indolelactate	131680318	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	CCBL1	9	131595221	indolelactate	131644773	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	True
rs15676	AMPD3	11	10329860	indolelactate	10529126	Metabolism	Nucleotide metabolism	True	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	PARVB	22	44395091	indolelactate	44568829	Cellular Processes		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs15676	SEC16A	9	139334549	indolelactate	139372141	Unknown		False	72	CCBL1	cysteine conjugate-beta lyase, cytoplasmic	Cytoplasm	enzyme	indolelactate	CCBL1 encodes a kyneurenine aminotransferase which can convert tryptophan to indolepyruvate [15606768].  Indolepyruvate is then converted to indolelactate.	CCBL1	ENDOG-FAT,ENDOG-LCL,ENDOG-Skin,PKN3-LCL,ZER1-Skin	NA	NA	NA	NA	CHEMBL3962	Compounds with activity in ChEMBL	NA	NA	ENDOG FAT ENDOG LCL ENDOG Skin PKN3 LCL ZER1 Skin	False	CCBL1	False
rs16876394	BHMT2	5	78365540	betaine	78385289	Metabolism	Amino acid metabolism	True	42	BHMT	betaine--homocysteine S-methyltransferase	Cytoplasm	enzyme	betaine	BHMT encodes a betaine-homocysteine methyltransferase which converts betaine to dimethylglycine [6746658].  The homologous enzyme encoded by the nearby BHMT2 gene cannot use betaine [18230605].	BHMT	BHMT-FAT,BHMT2-FAT	NA	Metabolite levels [23378610]	NA	NA	CHEMBL4328	Compounds with inhibitory activity in ChEMBL	NA	NA	BHMT FAT BHMT2 FAT	True	BHMT	True
rs16876394	BHMT	5	78407602	betaine	78428108	Metabolism	Amino acid metabolism	True	42	BHMT	betaine--homocysteine S-methyltransferase	Cytoplasm	enzyme	betaine	BHMT encodes a betaine-homocysteine methyltransferase which converts betaine to dimethylglycine [6746658].  The homologous enzyme encoded by the nearby BHMT2 gene cannot use betaine [18230605].	BHMT	BHMT-FAT,BHMT2-FAT	NA	Metabolite levels [23378610]	NA	NA	CHEMBL4328	Compounds with inhibitory activity in ChEMBL	NA	NA	BHMT FAT BHMT2 FAT	True	BHMT	True
rs1697421	NBPF3	1	21766621	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	21811498	Unknown		False	1	ALPL	alkaline phosphatase, liver/bone/kidney	Plasma Membrane	phosphatase	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	"ALPL encodes a phosphatase, which could possibly have a bearing on the phosphorylation state of fibrinogen.  The alpha chain of fibrinogen is known to be phosphorylated at Ser22 [16807684]. Ratio interpretation: indicates likely substrate/product pair ('activity').  ALPL plausibly affects phosphorylation state of fibrinogen
"	ALPL	ALPL-Skin	Phosphorus levels [20558539]	ADpSGEGDFXAEGGGVR*/DSGEGDFXAEGGGVR* [21886157] (r2=0.665 with rs10799701)	NA	NA	CHEMBL5979	Approved drugs with activity in ChEMBL	1	NA	ALPL Skin	True	ALPL	False
rs1697421	ALPL	1	21835858	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	21904905	Metabolism	Metabolism of cofactors and vitamins	True	1	ALPL	alkaline phosphatase, liver/bone/kidney	Plasma Membrane	phosphatase	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	"ALPL encodes a phosphatase, which could possibly have a bearing on the phosphorylation state of fibrinogen.  The alpha chain of fibrinogen is known to be phosphorylated at Ser22 [16807684]. Ratio interpretation: indicates likely substrate/product pair ('activity').  ALPL plausibly affects phosphorylation state of fibrinogen
"	ALPL	ALPL-Skin	Phosphorus levels [20558539]	ADpSGEGDFXAEGGGVR*/DSGEGDFXAEGGGVR* [21886157] (r2=0.665 with rs10799701)	NA	NA	CHEMBL5979	Approved drugs with activity in ChEMBL	1	NA	ALPL Skin	True	ALPL	True
rs1697421	NAV1	1	201598532	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	201796102	Unknown		False	1	ALPL	alkaline phosphatase, liver/bone/kidney	Plasma Membrane	phosphatase	DSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	"ALPL encodes a phosphatase, which could possibly have a bearing on the phosphorylation state of fibrinogen.  The alpha chain of fibrinogen is known to be phosphorylated at Ser22 [16807684]. Ratio interpretation: indicates likely substrate/product pair ('activity').  ALPL plausibly affects phosphorylation state of fibrinogen
"	ALPL	ALPL-Skin	Phosphorus levels [20558539]	ADpSGEGDFXAEGGGVR*/DSGEGDFXAEGGGVR* [21886157] (r2=0.665 with rs10799701)	NA	NA	CHEMBL5979	Approved drugs with activity in ChEMBL	1	NA	ALPL Skin	True	ALPL	False
rs170149	NFIX	19	13106422	citrate	13209610	Unknown		False	126	SLC13A5	solute carrier family 13 (sodium-dependent citrate transporter), member 5	Plasma Membrane	transporter	citrate	SLC13A5 encodes NaCT, a sodium-coupled citrate transporter [16973915]	SLC13A5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	SLC13A5	False
rs17134585	AKR1C3	10	5077546	androsterone sulfate/ epiandrosterone sulfate	5149878	Metabolism, Organismal Systems	Metabolism of cofactors and vitamins	True	76	AKR1C3|AKR1C4	aldo-keto reductase family 1, member C3/aldo-keto reductase family 1, member C4	Cytoplasm	enzyme	androsterone sulfate/ epiandrosterone sulfate	AKR1C4 encodes a 3 alpha-hydroxysteroid dehydrogenase (HSD) isoform which is expressed in liver and acts on androsterone.   The nearby gene AKR1C3 is expressed in prostate and mammary gland and the associated enzyme does not act on androsterone.  [15026176]. Ratio interpretation: both molecules are related to potential substrates ('selectivity').	AKR1C4	AKR1C3-Skin	NA	androsterone sulfate/epiandrosterone sulfate [21886157]	NA	ME	CHEMBL4681/CHEMBL4999	Substrates of AKR1Cs: carbonyl-containing xenobiotics as the tobacco-specific nitrosamine NNK: acetohexamide, daunorubicin, naloxone, naltrexone, befunolol, ethacrynic acid, ketoprofen, ketotifen, haloperidol, loxoprofen, metyrapone, oxonortyptyline, and numerous aromatic and aliphatic aldehydes (PMID: 15013815); Compounds and approved drugs with activity in ChEMBL	1	NA	AKR1C3 Skin	False	AKR1C4	False
rs17134585	RP11-445	10	5307996	androsterone sulfate/ epiandrosterone sulfate	5313199	Unknown		False	76	AKR1C3|AKR1C4	aldo-keto reductase family 1, member C3/aldo-keto reductase family 1, member C4	Cytoplasm	enzyme	androsterone sulfate/ epiandrosterone sulfate	AKR1C4 encodes a 3 alpha-hydroxysteroid dehydrogenase (HSD) isoform which is expressed in liver and acts on androsterone.   The nearby gene AKR1C3 is expressed in prostate and mammary gland and the associated enzyme does not act on androsterone.  [15026176]. Ratio interpretation: both molecules are related to potential substrates ('selectivity').	AKR1C4	AKR1C3-Skin	NA	androsterone sulfate/epiandrosterone sulfate [21886157]	NA	ME	CHEMBL4681/CHEMBL4999	Substrates of AKR1Cs: carbonyl-containing xenobiotics as the tobacco-specific nitrosamine NNK: acetohexamide, daunorubicin, naloxone, naltrexone, befunolol, ethacrynic acid, ketoprofen, ketotifen, haloperidol, loxoprofen, metyrapone, oxonortyptyline, and numerous aromatic and aliphatic aldehydes (PMID: 15013815); Compounds and approved drugs with activity in ChEMBL	1	NA	AKR1C3 Skin	False	AKR1C4	False
rs17134585	RSU1	10	16632610	androsterone sulfate/ epiandrosterone sulfate	16859527	Unknown		False	76	AKR1C3|AKR1C4	aldo-keto reductase family 1, member C3/aldo-keto reductase family 1, member C4	Cytoplasm	enzyme	androsterone sulfate/ epiandrosterone sulfate	AKR1C4 encodes a 3 alpha-hydroxysteroid dehydrogenase (HSD) isoform which is expressed in liver and acts on androsterone.   The nearby gene AKR1C3 is expressed in prostate and mammary gland and the associated enzyme does not act on androsterone.  [15026176]. Ratio interpretation: both molecules are related to potential substrates ('selectivity').	AKR1C4	AKR1C3-Skin	NA	androsterone sulfate/epiandrosterone sulfate [21886157]	NA	ME	CHEMBL4681/CHEMBL4999	Substrates of AKR1Cs: carbonyl-containing xenobiotics as the tobacco-specific nitrosamine NNK: acetohexamide, daunorubicin, naloxone, naltrexone, befunolol, ethacrynic acid, ketoprofen, ketotifen, haloperidol, loxoprofen, metyrapone, oxonortyptyline, and numerous aromatic and aliphatic aldehydes (PMID: 15013815); Compounds and approved drugs with activity in ChEMBL	1	NA	AKR1C3 Skin	False	AKR1C4	False
rs17279437	LIMD1	3	45596886	X-11315/ pyroglutamine	45727830	Environmental Information Processing		False	26	SLC6A20	solute carrier family 6 (proline IMINO transporter), member 20	Plasma Membrane	transporter	X-11315/ pyroglutamine	SLC6A20 encodes a transporter which can transport proline [19657969].  Pyroglutamine is structurally similar to proline. Ratio interpretation: n/a.	SLC6A20	NA	NA	Urinary metabolites [21572414]	Iminoglycinuria	NA	NA	NA	NA	NA	NA	False	SLC6A20	False
rs17279437	EXOSC7	3	45016733	X-11315/ pyroglutamine	45054160	Genetic Information Processing		False	26	SLC6A20	solute carrier family 6 (proline IMINO transporter), member 20	Plasma Membrane	transporter	X-11315/ pyroglutamine	SLC6A20 encodes a transporter which can transport proline [19657969].  Pyroglutamine is structurally similar to proline. Ratio interpretation: n/a.	SLC6A20	NA	NA	Urinary metabolites [21572414]	Iminoglycinuria	NA	NA	NA	NA	NA	NA	False	SLC6A20	False
rs174548	FADS1	11	61567099	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	61596790	Metabolism	Lipid metabolism	True	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	True
rs174548	FADS2	11	61583728	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	61634826	Metabolism, Organismal Systems	Lipid metabolism	True	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	TMEM258	11	61535973	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	61560108	Unknown		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	FADS3	11	61640991	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	61659523	Unknown		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	DDB1	11	61066923	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	61110045	Genetic Information Processing, Human Diseases		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	GANAB	11	62392298	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	62414104	Metabolism, Genetic Information Processing	Carbohydrate metabolism	True	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	RSF1	11	77371041	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	77532063	Unknown		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	PPME1	11	73882256	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	73965748	Unknown		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs174548	CAPN5	11	76777979	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	76837201	Unknown		False	88	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	arachidonate (20:4n6)/ dihomo-linolenate (20:3n3 or n6)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   The ratio of arachidonate (20:4n6) to dihomo‐linolenate (20:3n3 or n6) represents a product/substrate pair for FADS1. Ratio interpretation: n/a.	FADS1	FADS1-LIVER,FADS1-FAT,FADS3-LIVER	Cholesterol, total [20686565]; Comprehensive strength and appendicular lean mass [22960237]; Crohn's disease [21102463]; Fasting glucose-related traits [20081858]; Fasting glucose-related traits (interaction with BMI) [22581228]; HDL cholesterol [19060906,20864672,20686565]; Hematology traits [23303382]; LDL cholesterol [19060910,20686565]; Lipid metabolism phenotypes [22286219]; Metabolic syndrome [20694148]; Response to statin therapy [20339536]; Resting heart rate [20639392]; Triglycerides [19060906,20864672,20686565]	1-arachidonoylglycerophosphoethanolamine*/1-linoleoylglycerophosphoethanolamine* [21886157]; PC aa C36:3/PC aa C36:4 [20037589]; PC aa C36:4 [19043545]; Metabolite levels [19043545,23281178,22916037]; Oleic acid (18:1n-9) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512,21829377]; Stearic acid (18:0) plasma levels [23362303]; PC 38:4 [23823483]	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	FADS1 LIVER FADS1 FAT FADS3 LIVER	True	FADS1	False
rs17806888	SUCLG2	3	67410884	succinylcarnitine	67705038	Metabolism	Carbohydrate metabolism	True	28	SUCLG2	succinate-CoA ligase, GDP-forming, beta subunit	Cytoplasm	enzyme	succinylcarnitine	SUCLG2 encodes the beta subunit of succinate-CoA ligase which acts on succinate-CoA [18392745].  Acyl-CoAs and acyl-carnitines are readily interconverted.	SUCLG2	NA	Height [20881960]; Response to amphetamines [22952603]	NA	NA	NA	NA	NA	NA	NA	NA	False	SUCLG2	True
rs1800775	NLRC5	16	57023397	X-12038	57117443	Unknown		False	120	CETP	cholesteryl ester transfer protein, plasma	Extracellular Space	enzyme	X-12038	CETP encodes the cholesterylester transfer protein.  The gene is associated with LDL, HDL, total cholesterol and triglyceries in multiple GWAS [20686565]	CETP	CETP-LCL	Age-related macular degeneration [20385819,21665990]; ApoA-1 [17463246]; Triglycerides, HDL, LDL, Total cholesterol [20838585,21943158,19359809,19060906,20031564, 19060910,20686565,18193043,20694148,18454146,22286219,18193044,21386085]; Lipoprotein-associated phospholipase A2 activity and mass [22003152]	NA	NA	NA	CHEMBL3572	Compounds with activity in ChEMBL	10	26	CETP LCL	True	CETP	False
rs1800775	CETP	16	56995762	X-12038	57017757	Organismal Systems		False	120	CETP	cholesteryl ester transfer protein, plasma	Extracellular Space	enzyme	X-12038	CETP encodes the cholesterylester transfer protein.  The gene is associated with LDL, HDL, total cholesterol and triglyceries in multiple GWAS [20686565]	CETP	CETP-LCL	Age-related macular degeneration [20385819,21665990]; ApoA-1 [17463246]; Triglycerides, HDL, LDL, Total cholesterol [20838585,21943158,19359809,19060906,20031564, 19060910,20686565,18193043,20694148,18454146,22286219,18193044,21386085]; Lipoprotein-associated phospholipase A2 activity and mass [22003152]	NA	NA	NA	CHEMBL3572	Compounds with activity in ChEMBL	10	26	CETP LCL	True	CETP	True
rs1800775	CDH3	16	68670092	X-12038	68756519	Environmental Information Processing		False	120	CETP	cholesteryl ester transfer protein, plasma	Extracellular Space	enzyme	X-12038	CETP encodes the cholesterylester transfer protein.  The gene is associated with LDL, HDL, total cholesterol and triglyceries in multiple GWAS [20686565]	CETP	CETP-LCL	Age-related macular degeneration [20385819,21665990]; ApoA-1 [17463246]; Triglycerides, HDL, LDL, Total cholesterol [20838585,21943158,19359809,19060906,20031564, 19060910,20686565,18193043,20694148,18454146,22286219,18193044,21386085]; Lipoprotein-associated phospholipase A2 activity and mass [22003152]	NA	NA	NA	CHEMBL3572	Compounds with activity in ChEMBL	10	26	CETP LCL	True	CETP	False
rs1800775	NKD1	16	50582241	X-12038	50670647	Environmental Information Processing		False	120	CETP	cholesteryl ester transfer protein, plasma	Extracellular Space	enzyme	X-12038	CETP encodes the cholesterylester transfer protein.  The gene is associated with LDL, HDL, total cholesterol and triglyceries in multiple GWAS [20686565]	CETP	CETP-LCL	Age-related macular degeneration [20385819,21665990]; ApoA-1 [17463246]; Triglycerides, HDL, LDL, Total cholesterol [20838585,21943158,19359809,19060906,20031564, 19060910,20686565,18193043,20694148,18454146,22286219,18193044,21386085]; Lipoprotein-associated phospholipase A2 activity and mass [22003152]	NA	NA	NA	CHEMBL3572	Compounds with activity in ChEMBL	10	26	CETP LCL	True	CETP	False
rs1853207	HELLS	10	96305547	X-11247	96373662	Unknown		False	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1853207	CYP2C9	10	96698415	X-11247	96749147	Metabolism, Organismal Systems, Human Diseases	Xenobiotics biodegradation and metabolism	True	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1853207	C10orf129	10	96953957	X-11247	96988685	Unknown		False	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1853207	TBC1D12	10	96162261	X-11247	96295687	Unknown		False	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1853207	CYP2C18	10	96443251	X-11247	96495947	Metabolism, Organismal Systems, Human Diseases	Metabolism of cofactors and vitamins	True	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1853207	PDLIM1	10	96997329	X-11247	97050781	Unknown		False	80	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11247	X-11247 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [19300499]	X-11787 [23093944] (r2=0.764 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1934955	C10orf129	10	96953957	X-02249	96988685	Unknown		False	82	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8	Cytoplasm	enzyme	X-02249	X-02249 is an unknown metabolite	unknown	NA	NA	NA	NA	ME	CHEMBL3721	Substrates: Amodiaquine, Cerivastatin, paclitaxel, rosiglitazone, repaglinide; Inhibitors: gemfibrozil, montelukast, piolitazone, quercetin, rosiglitazone, rosuvastatin, trimethorprim	NA	NA	NA	False	unknown	False
rs1934955	NOC3L	10	96075085	X-02249	96122716	Unknown		False	82	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8	Cytoplasm	enzyme	X-02249	X-02249 is an unknown metabolite	unknown	NA	NA	NA	NA	ME	CHEMBL3721	Substrates: Amodiaquine, Cerivastatin, paclitaxel, rosiglitazone, repaglinide; Inhibitors: gemfibrozil, montelukast, piolitazone, quercetin, rosiglitazone, rosuvastatin, trimethorprim	NA	NA	NA	False	unknown	False
rs1934955	GPR158	10	25463991	X-02249	25891155	Unknown		False	82	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8	Cytoplasm	enzyme	X-02249	X-02249 is an unknown metabolite	unknown	NA	NA	NA	NA	ME	CHEMBL3721	Substrates: Amodiaquine, Cerivastatin, paclitaxel, rosiglitazone, repaglinide; Inhibitors: gemfibrozil, montelukast, piolitazone, quercetin, rosiglitazone, rosuvastatin, trimethorprim	NA	NA	NA	False	unknown	False
rs1934955	TLL2	10	98124363	X-02249	98273675	Unknown		False	82	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8	Cytoplasm	enzyme	X-02249	X-02249 is an unknown metabolite	unknown	NA	NA	NA	NA	ME	CHEMBL3721	Substrates: Amodiaquine, Cerivastatin, paclitaxel, rosiglitazone, repaglinide; Inhibitors: gemfibrozil, montelukast, piolitazone, quercetin, rosiglitazone, rosuvastatin, trimethorprim	NA	NA	NA	False	unknown	False
rs1934963	C10orf129	10	96953957	X-11787	96988685	Unknown		False	81	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11787	X-11787 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [18535201]	X-11787 [23093944] (r2=0.308 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1934963	CYP2C8	10	96796530	X-11787	96829254	Metabolism, Organismal Systems, Human Diseases	Xenobiotics biodegradation and metabolism	True	81	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11787	X-11787 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [18535201]	X-11787 [23093944] (r2=0.308 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs1934963	IDE	10	94211441	X-11787	94333833	Unknown		False	81	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-11787	X-11787 is an unknown metabolite	unknown	NA	Warfarin maintenance dose [18535201]	X-11787 [23093944] (r2=0.308 with rs7896133)	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	unknown	False
rs2007084	ANPEP	15	90328120	HWESASXX	90358633	Metabolism, Organismal Systems	Amino acid metabolism	True	112	ANPEP	alanyl (membrane) aminopeptidase	Plasma Membrane	peptidase	HWESASXX	ANPEP encodes Aminopeptidase N, which is a broad specificity aminopeptidase [7957888].  HWESASXX, a peptide derived from C3 complement [9647737], is a possible substrate	ANPEP	ANPEP-LIVER	NA	NA	NA	NA	CHEMBL1907	Compounds with activity in ChEMBL	5	7	ANPEP LIVER	True	ANPEP	True
rs2007084	PEX11A	15	90220995	HWESASXX	90234014	Cellular Processes		False	112	ANPEP	alanyl (membrane) aminopeptidase	Plasma Membrane	peptidase	HWESASXX	ANPEP encodes Aminopeptidase N, which is a broad specificity aminopeptidase [7957888].  HWESASXX, a peptide derived from C3 complement [9647737], is a possible substrate	ANPEP	ANPEP-LIVER	NA	NA	NA	NA	CHEMBL1907	Compounds with activity in ChEMBL	5	7	ANPEP LIVER	True	ANPEP	False
rs2007084	TNIK	3	170779128	HWESASXX	171178197	Unknown		False	112	ANPEP	alanyl (membrane) aminopeptidase	Plasma Membrane	peptidase	HWESASXX	ANPEP encodes Aminopeptidase N, which is a broad specificity aminopeptidase [7957888].  HWESASXX, a peptide derived from C3 complement [9647737], is a possible substrate	ANPEP	ANPEP-LIVER	NA	NA	NA	NA	CHEMBL1907	Compounds with activity in ChEMBL	5	7	ANPEP LIVER	True	ANPEP	False
rs2062541	ABCC1	16	16043434	hexanoylcarnitine/ octanoylcarnitine	16236931	Environmental Information Processing, Organismal Systems, Human Diseases		False	115	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	Plasma Membrane	transporter	hexanoylcarnitine/ octanoylcarnitine	Hexanoylcarnitine and octanoylcarnitine are short chain acyl carnitines.  Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	TP	CHEMBL3004	No specific drug is primarily metabolised by this enzyme; compounds and approved drugs (Lamivudine, Tenofovir) with activity in ChEMBL	2	10	NA	False	unknown	False
rs2066938	SPPL3	12	121200313	butyrylcarnitine	121342174	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2066938	C12orf43	12	121440316	butyrylcarnitine	121454305	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2066938	ACADS	12	121163538	butyrylcarnitine	121177811	Metabolism	Amino acid metabolism	True	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	True
rs2066938	UNC119B	12	121148238	butyrylcarnitine	121161443	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2066938	MLEC	12	121124672	butyrylcarnitine	121139667	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2066938	RP11-173	12	121178273	butyrylcarnitine	121199395	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2066938	FBXO21	12	117581146	butyrylcarnitine	117628336	Unknown		False	99	ACADS	SH2B adaptor protein 3	Plasma Membrane	other	butyrylcarnitine	ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357].  Butyryl-CoA and butyrylcarnitine readily interconvert.  Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177].	ACADS	MLEC-FAT	NA	butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589]	Short chain acyl-CoA dehydrogenase deficiency.	NA	NA	NA	NA	NA	MLEC FAT	False	ACADS	False
rs2070895	LIPC	15	58702768	1-palmitoylglycero-phosphoethanolamine	58861151	Metabolism, Organismal Systems	Lipid metabolism	True	109	LIPC	lipase, hepatic	Extracellular Space	enzyme	1-palmitoylglycero-phosphoethanolamine	LIPC encodes hepatic lipase with activity against both triacylglycerols and phospholipids [6511790].  Hydrolysis of phospholipids generates lysolipids and fatty acids.	LIPC	LIPC-LIVER	HDL cholesterol [18193044,20864672]	Metabolite levels [23281178]	NA	NA	CHEMBL2127	Compounds with no activity in ChEMBL	NA	NA	LIPC LIVER	True	LIPC	True
rs2070895	CPQ	8	97657455	1-palmitoylglycero-phosphoethanolamine	98161882	Unknown		False	109	LIPC	lipase, hepatic	Extracellular Space	enzyme	1-palmitoylglycero-phosphoethanolamine	LIPC encodes hepatic lipase with activity against both triacylglycerols and phospholipids [6511790].  Hydrolysis of phospholipids generates lysolipids and fatty acids.	LIPC	LIPC-LIVER	HDL cholesterol [18193044,20864672]	Metabolite levels [23281178]	NA	NA	CHEMBL2127	Compounds with no activity in ChEMBL	NA	NA	LIPC LIVER	True	LIPC	False
rs2160860	IDO2	8	39792133	X-12100--hydroxytryptophan*	39873910	Metabolism, Human Diseases	Amino acid metabolism	True	68	IDO1	indoleamine 2,3-dioxygenase 1	Cytoplasm	enzyme	X-12100--hydroxytryptophan*	IDO1 and IDO2 encode the two indoleamine 2,3-dioxygenase isozymes.  Both enzymes take tryptophan and tryptophan-related metabolites as substrates, but IDO1 is more active [18282734].  IDO1 has known activity against 5-hydroxy-tryptophan [10833386].  X-12100 was identified as hydroxytryptophan.	IDO1	NA	NA	NA	NA	NA	CHEMBL4685	Compounds with activity in ChEMBL	5	3	NA	False	IDO1	False
rs2160860	IDO1	8	39759794	X-12100--hydroxytryptophan*	39785963	Metabolism, Human Diseases	Amino acid metabolism	True	68	IDO1	indoleamine 2,3-dioxygenase 1	Cytoplasm	enzyme	X-12100--hydroxytryptophan*	IDO1 and IDO2 encode the two indoleamine 2,3-dioxygenase isozymes.  Both enzymes take tryptophan and tryptophan-related metabolites as substrates, but IDO1 is more active [18282734].  IDO1 has known activity against 5-hydroxy-tryptophan [10833386].  X-12100 was identified as hydroxytryptophan.	IDO1	NA	NA	NA	NA	NA	CHEMBL4685	Compounds with activity in ChEMBL	5	3	NA	False	IDO1	True
rs2187375	LIPG	18	47087069	X-03094	47119272	Metabolism, Organismal Systems	Lipid metabolism	True	131	LIPG	lipase, endothelial	Extracellular Space	enzyme	X-03094	LIPG, the endothelial lipase, has been associated with HDL cholesterol in many studies [22607825].   X-03094 is a GGM neighbor of cholesterol [23093944].	LIPG	LIPG-LCL	Cholesterol, total [19060911,20686565]; HDL cholesterol [20031538,19060906,18193044,18193043,20864672,19060911,20686565]	NA	NA	NA	CHEMBL5080	Compounds with activity in ChEMBL	NA	NA	LIPG LCL	True	LIPG	True
rs2235649	TELO2	16	1543345	X-12556	1560427	Genetic Information Processing, Environmental Information Processing		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	HAGH	16	1845621	X-12556	1876967	Metabolism	Carbohydrate metabolism	True	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	NUBP2	16	1832902	X-12556	1839192	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	FAHD1	16	1877196	X-12556	1890208	Metabolism	Amino acid metabolism	True	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	EME2	16	1823208	X-12556	1831709	Genetic Information Processing		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	CHTF18	16	838046	X-12556	850737	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	MRPS34	16	1821891	X-12556	1823156	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	NME3	16	1820319	X-12556	1821731	Metabolism	Xenobiotics biodegradation and metabolism	True	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	MEIOB	16	1883984	X-12556	1934295	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	IGFALS	16	1840414	X-12556	1844972	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	OXR1	8	107371704	X-12556	107764922	Unknown		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2235649	MMP25	16	3096682	X-12556	3110727	Organismal Systems		False	113	NUBP2	nucleotide binding protein 2	Nucleus	other	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2270968	MCCC1-AS1	3	182734043	hydroxyisovaleroyl carnitine	182735596	Unknown		False	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	True
rs2270968	MCCC1	3	182733006	hydroxyisovaleroyl carnitine	182833863	Metabolism	Amino acid metabolism	True	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	True
rs2270968	DCUN1D1	3	182655862	hydroxyisovaleroyl carnitine	182703741	Unknown		False	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	False
rs2270968	ATP11B	3	182511288	hydroxyisovaleroyl carnitine	182639027	Unknown		False	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	False
rs2270968	BASP1	5	17065707	hydroxyisovaleroyl carnitine	17276943	Unknown		False	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	False
rs2270968	RPL39L	3	186838736	hydroxyisovaleroyl carnitine	186898696	Unknown		False	30	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)	Cytoplasm	enzyme	hydroxyisovaleroyl carnitine	Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287]	MCCC1	MCCC1-LCL	NA	NA	Isolated 3-methylcrotonyl-CoA carboxylase deficiency	NA	NA	NA	NA	NA	MCCC1 LCL	True	MCCC1	False
rs2271316	RP11-589	17	6897961	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	6898508	Unknown		False	128	ALOX12	arachidonate 12-lipoxygenase	Cytoplasm	enzyme	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	ALOX12 encodes arachidonate 12-lipoxygenase which catalyzes the regio-selective addition of oxygen into arachidonic acid, generating 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE), which is rapidly reduced to the corresponding 12S-hydroxy compound, 12-HETE [4215079, 2377602 ].  X-12441 is 12-HETE [23093944]	ALOX12	NA	NA	NA	NA	NA	CHEMBL3687	Compounds with activity in ChEMBL	NA	11	NA	False	ALOX12	False
rs2271316	ALOX12	17	6899384	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	6914055	Metabolism, Organismal Systems, Human Diseases	Lipid metabolism	True	128	ALOX12	arachidonate 12-lipoxygenase	Cytoplasm	enzyme	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	ALOX12 encodes arachidonate 12-lipoxygenase which catalyzes the regio-selective addition of oxygen into arachidonic acid, generating 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE), which is rapidly reduced to the corresponding 12S-hydroxy compound, 12-HETE [4215079, 2377602 ].  X-12441 is 12-HETE [23093944]	ALOX12	NA	NA	NA	NA	NA	CHEMBL3687	Compounds with activity in ChEMBL	NA	11	NA	False	ALOX12	True
rs2271316	AC027763.2	17	6779954	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	6915668	Unknown		False	128	ALOX12	arachidonate 12-lipoxygenase	Cytoplasm	enzyme	X-12441--12-hydroxyeicosatetraenoate (12-HETE)	ALOX12 encodes arachidonate 12-lipoxygenase which catalyzes the regio-selective addition of oxygen into arachidonic acid, generating 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE), which is rapidly reduced to the corresponding 12S-hydroxy compound, 12-HETE [4215079, 2377602 ].  X-12441 is 12-HETE [23093944]	ALOX12	NA	NA	NA	NA	NA	CHEMBL3687	Compounds with activity in ChEMBL	NA	11	NA	False	ALOX12	False
rs2404602	SCAPER	15	76640526	isobutyrylcarnitine	77197785	Unknown		False	111	SCAPER	S-phase cyclin A-associated protein in the ER	Extracellular Space	other	isobutyrylcarnitine	Isobutyrylcarnitine is a short chain acyl carnitine related to some branched chain amino acid degradation products	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2404602	RP11-593	15	76467232	isobutyrylcarnitine	76473827	Unknown		False	111	SCAPER	S-phase cyclin A-associated protein in the ER	Extracellular Space	other	isobutyrylcarnitine	Isobutyrylcarnitine is a short chain acyl carnitine related to some branched chain amino acid degradation products	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2405522	SLC22A5	5	131705444	tryptophan betaine	131731306	Human Diseases		False	44	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	tryptophan betaine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters.  OCTN1 transports tetraethyl ammonium and thus may be responsible for the association with tryptophan betaine [9426230].	SLC22A5	IL5-Skin,RAD50-FAT,SLC22A5-LIVER,SLC22A5-LCL	Crohn's disease [17554300]	NA	NA	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	IL5 Skin RAD50 FAT SLC22A5 LIVER SLC22A5 LCL	True	SLC22A5	True
rs2405522	AC034220.3	5	131646978	tryptophan betaine	131705340	Unknown		False	44	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	tryptophan betaine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters.  OCTN1 transports tetraethyl ammonium and thus may be responsible for the association with tryptophan betaine [9426230].	SLC22A5	IL5-Skin,RAD50-FAT,SLC22A5-LIVER,SLC22A5-LCL	Crohn's disease [17554300]	NA	NA	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	IL5 Skin RAD50 FAT SLC22A5 LIVER SLC22A5 LCL	True	SLC22A5	False
rs2405522	AFF4	5	132211071	tryptophan betaine	132299326	Unknown		False	44	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	tryptophan betaine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters.  OCTN1 transports tetraethyl ammonium and thus may be responsible for the association with tryptophan betaine [9426230].	SLC22A5	IL5-Skin,RAD50-FAT,SLC22A5-LIVER,SLC22A5-LCL	Crohn's disease [17554300]	NA	NA	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	IL5 Skin RAD50 FAT SLC22A5 LIVER SLC22A5 LCL	True	SLC22A5	False
rs2540647	DGCR9	22	19005347	valine/ proline	19007761	Unknown		False	141	PRODH	proline dehydrogenase (oxidase) 1	Cytoplasm	enzyme	valine/ proline	PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation [16874462]. Ratio interpretation: PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation.  Valine may normalize for the amino acid pool ('normalizing').	PRODH	PRODH-FAT,PRODH-Skin	NA	proline [21886157]; Proline [23823483]	Hyperprolinaemia type I	NA	NA	NA	NA	NA	PRODH FAT PRODH Skin	True	PRODH	False
rs2540647	PRODH	22	18904403	valine/ proline	18924066	Metabolism	Amino acid metabolism	True	141	PRODH	proline dehydrogenase (oxidase) 1	Cytoplasm	enzyme	valine/ proline	PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation [16874462]. Ratio interpretation: PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation.  Valine may normalize for the amino acid pool ('normalizing').	PRODH	PRODH-FAT,PRODH-Skin	NA	proline [21886157]; Proline [23823483]	Hyperprolinaemia type I	NA	NA	NA	NA	NA	PRODH FAT PRODH Skin	True	PRODH	True
rs2547231	CTD-3098	19	48366740	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	48368598	Unknown		False	136	SULT2A1	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1	Cytoplasm	enzyme	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	SULT2A1 catalyzes the sulfation of a wide range of steroids and bile acids [9034160].  SNPs near SULT2A1 have been associated with dehydroepiandrosterone sulphate levels [21533175]. Ratio interpretation: SULT2A1 catalyzes sulfation of steroids.  Molecules may represent a range of products.  X-11440 is hydroxypregnen-diol disulfate or pregnanolone-diol disulfate (possible 'selectivity')	SULT2A1	SULT2A1-LIVER	NA	X-11440,X-11244 [23093944]	NA	ME	CHEMBL2077	Substrates: Dehydroepiandrosterone (DHEA), 1-hydroxymethylpyrene, 6-hydroxymethylbenzoapyrene, hycanthone, bile acids, pregnenolone, testosterone, androgens, estrone, 17β-estradiol, other hydroxysteroids, budenoside	NA	NA	SULT2A1 LIVER	True	SULT2A1	False
rs2547231	SULT2A1	19	48373723	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	48389654	Metabolism, Organismal Systems, Human Diseases	Xenobiotics biodegradation and metabolism	True	136	SULT2A1	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1	Cytoplasm	enzyme	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	SULT2A1 catalyzes the sulfation of a wide range of steroids and bile acids [9034160].  SNPs near SULT2A1 have been associated with dehydroepiandrosterone sulphate levels [21533175]. Ratio interpretation: SULT2A1 catalyzes sulfation of steroids.  Molecules may represent a range of products.  X-11440 is hydroxypregnen-diol disulfate or pregnanolone-diol disulfate (possible 'selectivity')	SULT2A1	SULT2A1-LIVER	NA	X-11440,X-11244 [23093944]	NA	ME	CHEMBL2077	Substrates: Dehydroepiandrosterone (DHEA), 1-hydroxymethylpyrene, 6-hydroxymethylbenzoapyrene, hycanthone, bile acids, pregnenolone, testosterone, androgens, estrone, 17β-estradiol, other hydroxysteroids, budenoside	NA	NA	SULT2A1 LIVER	True	SULT2A1	True
rs2547231	ZNF430	19	21203426	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	21242856	Unknown		False	136	SULT2A1	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1	Cytoplasm	enzyme	X-11440/ 4-androsten-3beta,17beta-diol disulfate 2	SULT2A1 catalyzes the sulfation of a wide range of steroids and bile acids [9034160].  SNPs near SULT2A1 have been associated with dehydroepiandrosterone sulphate levels [21533175]. Ratio interpretation: SULT2A1 catalyzes sulfation of steroids.  Molecules may represent a range of products.  X-11440 is hydroxypregnen-diol disulfate or pregnanolone-diol disulfate (possible 'selectivity')	SULT2A1	SULT2A1-LIVER	NA	X-11440,X-11244 [23093944]	NA	ME	CHEMBL2077	Substrates: Dehydroepiandrosterone (DHEA), 1-hydroxymethylpyrene, 6-hydroxymethylbenzoapyrene, hycanthone, bile acids, pregnenolone, testosterone, androgens, estrone, 17β-estradiol, other hydroxysteroids, budenoside	NA	NA	SULT2A1 LIVER	True	SULT2A1	False
rs2576452	TMC4	19	54663846	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	54676944	Unknown		False	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	False
rs2576452	MBOAT7	19	54677107	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	54693733	Metabolism	Lipid metabolism	True	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	True
rs2576452	AC012314.8	19	54622891	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	54628722	Unknown		False	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	False
rs2576452	PRPF31	19	54619056	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	54635140	Genetic Information Processing		False	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	False
rs2576452	ANKFY1	17	4067201	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	4167274	Unknown		False	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	False
rs2576452	MYO9B	19	17186591	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	17325346	Unknown		False	138	MBOAT7	membrane bound O-acyltransferase domain containing 7	Plasma Membrane	other	arachidonate (20:4n6)/ 1-arachidonoylglycero-phosphoinositol	MBOAT7 encodes a lysophosphatidylinositol acyltransferase that has specificity for arachidonoyl-CoA as an acyl donor [18094042].  Arachidonate is readily converted to arachidonoyl-CoA.  Thus the associated ratio is closely linked to the substrate/product pair for this enzyme. Ratio interpretation: The associated ratio is closely linked to the substrate/product pair for this enzyme ('activity')	MBOAT7	MBOAT7-LIVER,TMC4-LIVER,TMC4-FAT,TMC4-Skin	NA	NA	NA	NA	NA	NA	NA	NA	MBOAT7 LIVER TMC4 LIVER TMC4 FAT TMC4 Skin	True	MBOAT7	False
rs2694917	SPRYD4	12	56862301	glutamine/ histidine	56864735	Unknown		False	96	GLS2	solute carrier organic anion transporter family, member 1B1	Plasma Membrane	transporter	glutamine/ histidine	"GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation:  GLS2 produces glutamine.  Histidine may normalize for the amino acid pool ('normalizing').
"	GLS2	GLS2-LCL,GLS2-Skin,RBMS2-LCL,SPRYD4-FAT,SPRYD4-LCL,SPRYD4-Skin	NA	Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879)	NA	NA	NA	NA	NA	NA	GLS2 LCL GLS2 Skin RBMS2 LCL SPRYD4 FAT SPRYD4 LCL SPRYD4 Skin	True	GLS2	False
rs2694917	RP11-977	12	56693926	glutamine/ histidine	56708592	Unknown		False	96	GLS2	solute carrier organic anion transporter family, member 1B1	Plasma Membrane	transporter	glutamine/ histidine	"GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation:  GLS2 produces glutamine.  Histidine may normalize for the amino acid pool ('normalizing').
"	GLS2	GLS2-LCL,GLS2-Skin,RBMS2-LCL,SPRYD4-FAT,SPRYD4-LCL,SPRYD4-Skin	NA	Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879)	NA	NA	NA	NA	NA	NA	GLS2 LCL GLS2 Skin RBMS2 LCL SPRYD4 FAT SPRYD4 LCL SPRYD4 Skin	True	GLS2	False
rs2694917	RBMS2	12	56915713	glutamine/ histidine	56984745	Unknown		False	96	GLS2	solute carrier organic anion transporter family, member 1B1	Plasma Membrane	transporter	glutamine/ histidine	"GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation:  GLS2 produces glutamine.  Histidine may normalize for the amino acid pool ('normalizing').
"	GLS2	GLS2-LCL,GLS2-Skin,RBMS2-LCL,SPRYD4-FAT,SPRYD4-LCL,SPRYD4-Skin	NA	Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879)	NA	NA	NA	NA	NA	NA	GLS2 LCL GLS2 Skin RBMS2 LCL SPRYD4 FAT SPRYD4 LCL SPRYD4 Skin	True	GLS2	False
rs2694917	CNPY2	12	56703626	glutamine/ histidine	56710006	Unknown		False	96	GLS2	solute carrier organic anion transporter family, member 1B1	Plasma Membrane	transporter	glutamine/ histidine	"GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation:  GLS2 produces glutamine.  Histidine may normalize for the amino acid pool ('normalizing').
"	GLS2	GLS2-LCL,GLS2-Skin,RBMS2-LCL,SPRYD4-FAT,SPRYD4-LCL,SPRYD4-Skin	NA	Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879)	NA	NA	NA	NA	NA	NA	GLS2 LCL GLS2 Skin RBMS2 LCL SPRYD4 FAT SPRYD4 LCL SPRYD4 Skin	True	GLS2	False
rs2694917	RPAP3	12	48057070	glutamine/ histidine	48099844	Unknown		False	96	GLS2	solute carrier organic anion transporter family, member 1B1	Plasma Membrane	transporter	glutamine/ histidine	"GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation:  GLS2 produces glutamine.  Histidine may normalize for the amino acid pool ('normalizing').
"	GLS2	GLS2-LCL,GLS2-Skin,RBMS2-LCL,SPRYD4-FAT,SPRYD4-LCL,SPRYD4-Skin	NA	Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879)	NA	NA	NA	NA	NA	NA	GLS2 LCL GLS2 Skin RBMS2 LCL SPRYD4 FAT SPRYD4 LCL SPRYD4 Skin	True	GLS2	False
rs2727271	FADS1	11	61567099	X-12990--docosapentaenoic acid (n6-DPA)	61596790	Metabolism	Lipid metabolism	True	89	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	X-12990--docosapentaenoic acid (n6-DPA)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   X-12990 is docosapentaenoic acid which may be derived from arachidonic acid; arachidonic acid is derived via the activity of the FADS1 encoded delta-5 desaturase [9704073].	FADS1	NA	NA	NA	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	NA	False	FADS1	True
rs2727271	FADS3	11	61640991	X-12990--docosapentaenoic acid (n6-DPA)	61659523	Unknown		False	89	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	X-12990--docosapentaenoic acid (n6-DPA)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   X-12990 is docosapentaenoic acid which may be derived from arachidonic acid; arachidonic acid is derived via the activity of the FADS1 encoded delta-5 desaturase [9704073].	FADS1	NA	NA	NA	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	NA	False	FADS1	False
rs2727271	INCENP	11	61891445	X-12990--docosapentaenoic acid (n6-DPA)	61920635	Unknown		False	89	FADS1-3	fatty acid desaturase 1-3	Plasma Membrane	enzyme	X-12990--docosapentaenoic acid (n6-DPA)	FADS1, FADS2 and FADS3 encode three homologous fatty acid desaturases; FADS1 is a delta-5 desaturase, FADS2 is a delta-6 desaturase, and the catalytic activity of FADS3 is unknown [10601301].   X-12990 is docosapentaenoic acid which may be derived from arachidonic acid; arachidonic acid is derived via the activity of the FADS1 encoded delta-5 desaturase [9704073].	FADS1	NA	NA	NA	NA	NA	NA	Compounds with activity in ChEMBL for FADS2	NA	NA	NA	False	FADS1	False
rs272889	AC034220.3	5	131646978	valine/ isovalerylcarnitine	131705340	Unknown		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	SLC22A5	5	131705444	valine/ isovalerylcarnitine	131731306	Human Diseases		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	True
rs272889	P4HA2	5	131527531	valine/ isovalerylcarnitine	131631008	Metabolism	Amino acid metabolism	True	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	SLC22A4	5	131630136	valine/ isovalerylcarnitine	131679899	Human Diseases		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	RAPGEF6	5	130759614	valine/ isovalerylcarnitine	130970929	Environmental Information Processing, Cellular Processes		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	KIF3A	5	132028320	valine/ isovalerylcarnitine	132073330	Environmental Information Processing		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	PDLIM4	5	131593364	valine/ isovalerylcarnitine	131609147	Unknown		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	ACSL6	5	131142683	valine/ isovalerylcarnitine	131347936	Metabolism, Cellular Processes, Organismal Systems	Lipid metabolism	True	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	IRF1	5	131817301	valine/ isovalerylcarnitine	131826490	Environmental Information Processing, Organismal Systems, Human Diseases		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs272889	AC063976.7	5	131535149	valine/ isovalerylcarnitine	131539180	Unknown		False	43	SLC22A4|SLC22A5	solute carrier family 22 (organic cation/ergothioneine transporter), member 4/solute carrier family 22 (organic cation/carnitine transporter), member 5	Plasma Membrane	transporter	valine/ isovalerylcarnitine	SLC22A4 and SLC22A5 encode the OCTN1 and OCTN2 organic cation transporters and both have documented carnitine transport activity [21045919]. Ratio interpretation: isovalerylcarnitine is related to isovaleryl-CoA, an intermediate in the breakdown of branch chain amino acid, leucine.  Valine, as an additional branch chain amino acid, may be normalizing for the branch chain amino acid pool ('normalizing').	SLC22A5	SLC22A4-Skin,P4HA2-LCL,P4HA2-Skin,PDLIM4-Skin,RAD50-FAT,RAD50-LCL,SLC22A5-LCL,SLC22A5-Skin	Height [20881960]	isovalerylcarnitine [21886157]; Valine/C5 [20037589]	"Carnitine brain transporter deficiency
Primary systemic carnitine deficiency"	TP/TP	CHEMBL2073668/CHEMBL2073693	No specific drug is associated with this transporter (PMID:20190787)	NA	NA	SLC22A4 Skin P4HA2 LCL P4HA2 Skin PDLIM4 Skin RAD50 FAT RAD50 LCL SLC22A5 LCL SLC22A5 Skin	True	SLC22A5	False
rs2731672	RAB24	5	176728452	X-12038/ bradykinin, des-arg(9)	176730745	Unknown		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	False
rs2731672	LMAN2	5	176758563	X-12038/ bradykinin, des-arg(9)	176778853	Genetic Information Processing		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	False
rs2731672	F12	5	176829141	X-12038/ bradykinin, des-arg(9)	176836577	Organismal Systems		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	True
rs2731672	GPRIN1	5	176022976	X-12038/ bradykinin, des-arg(9)	176037134	Unknown		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	False
rs2731672	MXD3	5	176732501	X-12038/ bradykinin, des-arg(9)	176739758	Unknown		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	False
rs2731672	PRELID1	5	176730775	X-12038/ bradykinin, des-arg(9)	176731851	Unknown		False	45	F12	coagulation factor XII (Hageman factor)	Extracellular Space	peptidase	X-12038/ bradykinin, des-arg(9)	F12 encodes the factor XII serine protease which activates kallikrein [3521732] which releases bradykinin from kininogen. Ratio interpretation: n/a.	F12	F12-LIVER,F12-LCL,RAB24-FAT,RAB24-LCL,RAB24-Skin	Activated partial thromboplastin time [20303064,22703881]; Circulating vasoactive peptide levels [23381795]; Platelet function and related traits [21546496]	Phe [22286219]; Metabolite levels [22916037];	NA	NA	CHEMBL2821	Compounds with activity in ChEMBL	NA	3	F12 LIVER F12 LCL RAB24 FAT RAB24 LCL RAB24 Skin	True	F12	False
rs2734331	HLA-DQB2	6	32723875	X-11470	32731311	Unknown		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	NEU1	6	31826829	X-11470	31830683	Metabolism, Cellular Processes	Carbohydrate metabolism	True	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	LY6G5C	6	31644461	X-11470	31651817	Unknown		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	HLA-DQB1	6	32627244	X-11470	32636160	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	HCG27	6	31165915	X-11470	31171745	Unknown		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	ATF6B	6	32083112	X-11470	32096030	Genetic Information Processing, Environmental Information Processing, Organismal Systems, Human Diseases		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2734331	PPP1R10	6	30568177	X-11470	30586389	Unknown		False	51	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)	Nucleus	enzyme	X-11470	X-11470 is a GGM neighbor of cortisol [23093944].	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	PDXDC1	16	15068448	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15233196	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	RP11-72I	16	15188268	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15203054	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	RP11-680	16	15111963	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15114345	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	RRN3	16	15153879	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15188174	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	PKD1P6	16	15219099	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15248421	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	NTAN1	16	15131710	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	15149921	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2740	DLGAP4	20	34894258	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	35157040	Unknown		False	114	PDXDC1	pyridoxal-dependent decarboxylase domain containing 1	unknown	other	linoleate (18:2n6)/ dihomo-linolenate (20:3n3 or n6)	Linoleate and dihomo-linolenate are unsaturated long chain fatty acids.  PDXDC1 probably encodes a pyridoxal phosphate-dependent decarboxylase. Ratio interpretation: n/a.	unknown	NA	Height [20189936]	1-eicosatrienoylglycerophosphocholine*/1-linoleoylglycerophosphocholine [21886157]; Phospholipid levels (plasma) [22359512]; CE 20:3 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs2851391	PKNOX1	21	44394620	betaine	44453691	Unknown		False	140	CBS	cystathionine-beta-synthase	Cytoplasm	enzyme	betaine	"CBS encodes cystathionine-beta-synthase which converts homocysteine to cystathione.  Alternatively, homocysteine can be converted to methionine in a reaction which uses betaine as a methyl donor [16545978].
"	CBS	CBS-FAT,CBS-LCL,CBS-Skin	Obesity-related traits [23251661]	NA	Classical homocystinuria due to cystathionine beta-synthase (CbS) deficiency	NA	NA	NA	NA	1	CBS FAT CBS LCL CBS Skin	True	CBS	False
rs2851391	CBS	21	44473301	betaine	44497053	Metabolism	Amino acid metabolism	True	140	CBS	cystathionine-beta-synthase	Cytoplasm	enzyme	betaine	"CBS encodes cystathionine-beta-synthase which converts homocysteine to cystathione.  Alternatively, homocysteine can be converted to methionine in a reaction which uses betaine as a methyl donor [16545978].
"	CBS	CBS-FAT,CBS-LCL,CBS-Skin	Obesity-related traits [23251661]	NA	Classical homocystinuria due to cystathionine beta-synthase (CbS) deficiency	NA	NA	NA	NA	1	CBS FAT CBS LCL CBS Skin	True	CBS	True
rs316020	LPAL2	6	160880088	X-12798/ phenylalanine	160932156	Unknown		False	56	SLC22A1|SLC22A2	solute carrier family 22 (organic cation transporter), member 1/solute carrier family 22 (organic cation transporter), member 2	Plasma Membrane	transporter	X-12798/ phenylalanine	SLC22A1 and SLC22A2 encode the Oct1 and Oct2 organic cation transporters.  These transporters are not known to specifically transport phenylalanine, but Oct1 has been shown to transport dopamine, a neurotransmitter which can be synthesized from phenylalanine [9260930]. Ratio interpretation: n/a.	SLC22A1	NA	NA	X-12798 [23093944]	NA	TP/TP	CHEMBL5685/CHEMBL1743122	Substrates of SLC22A1: Tetraethylammonium, N-methylpyridinium, metformin*, oxaliplatin; Inhibitors of SLC22A1: Quinine, quinidine, disopyramide; Substrates of SLC22A2: N-Methylpyridinium, tetraethylammonium, metformin*, pindolol, procainamide, ranitidine amantadine, amiloride, oxaliplatin, varenicline; Inhibitors of SLC22A2: Cimetidine*, pilsicainide, cetirizine*, testosterone, quinidine; (PMID: 20190787)	NA	NA	NA	False	SLC22A1	False
rs316020	GRM1	6	146348782	X-12798/ phenylalanine	146758734	Environmental Information Processing, Cellular Processes, Organismal Systems		False	56	SLC22A1|SLC22A2	solute carrier family 22 (organic cation transporter), member 1/solute carrier family 22 (organic cation transporter), member 2	Plasma Membrane	transporter	X-12798/ phenylalanine	SLC22A1 and SLC22A2 encode the Oct1 and Oct2 organic cation transporters.  These transporters are not known to specifically transport phenylalanine, but Oct1 has been shown to transport dopamine, a neurotransmitter which can be synthesized from phenylalanine [9260930]. Ratio interpretation: n/a.	SLC22A1	NA	NA	X-12798 [23093944]	NA	TP/TP	CHEMBL5685/CHEMBL1743122	Substrates of SLC22A1: Tetraethylammonium, N-methylpyridinium, metformin*, oxaliplatin; Inhibitors of SLC22A1: Quinine, quinidine, disopyramide; Substrates of SLC22A2: N-Methylpyridinium, tetraethylammonium, metformin*, pindolol, procainamide, ranitidine amantadine, amiloride, oxaliplatin, varenicline; Inhibitors of SLC22A2: Cimetidine*, pilsicainide, cetirizine*, testosterone, quinidine; (PMID: 20190787)	NA	NA	NA	False	SLC22A1	False
rs3184504	ALDH2	12	112204691	kynurenine	112247782	Metabolism	Amino acid metabolism	True	98	SH2B3	phenylalanine hydroxylase	Cytoplasm	enzyme	kynurenine	Kynurenine is derived from tryptophan metabolism	unknown	NA	Beta-2 microglubulin plasma levels [23417110]; Blood pressure [21909110]; Celiac disease [18311140,20190752]; Celiac disease and Rheumatoid arthritis [21383967]; Chronic kidney disease [20383146]; Coronary heart disease [21378990]; Diastolic blood pressure [19430483,19430479,21909115]; Eosinophil counts [19198610]; Hypothyroidism [22493691]; Platelet counts [22139419]; Red blood cell traits [23222517]; Retinal vascular caliber [21060863]; Rheumatoid arthritis [20453842]; Systolic blood pressure [19430479]; Type 1 diabetes [19430480]; Type 1 diabetes autoantibodies [21829393]; Urate levels [23263486]; Vitiligo [22561518]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs3184504	FAM216A	12	110906181	kynurenine	110928190	Unknown		False	98	SH2B3	phenylalanine hydroxylase	Cytoplasm	enzyme	kynurenine	Kynurenine is derived from tryptophan metabolism	unknown	NA	Beta-2 microglubulin plasma levels [23417110]; Blood pressure [21909110]; Celiac disease [18311140,20190752]; Celiac disease and Rheumatoid arthritis [21383967]; Chronic kidney disease [20383146]; Coronary heart disease [21378990]; Diastolic blood pressure [19430483,19430479,21909115]; Eosinophil counts [19198610]; Hypothyroidism [22493691]; Platelet counts [22139419]; Red blood cell traits [23222517]; Retinal vascular caliber [21060863]; Rheumatoid arthritis [20453842]; Systolic blood pressure [19430479]; Type 1 diabetes [19430480]; Type 1 diabetes autoantibodies [21829393]; Urate levels [23263486]; Vitiligo [22561518]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs3738934	RPE	2	210867289	X-13431--nonanoylcarnitine*	210886146	Metabolism	Carbohydrate metabolism	True	21	ACADL	acyl-CoA dehydrogenase, long chain	Cytoplasm	enzyme	X-13431--nonanoylcarnitine*	ACADL encodes Long-chain acyl-CoA dehydrogenase which has activity against a variety of medium and long chain acyl-CoAs [10832093].  X-13431 has been identified as nonaylcarnitine (C9:0) [23093944].  Acyl-CoAs and acyl-carnitines are readily interconverted.	ACADL	NA	NA	C9/C10:2 [20037589]; X-13431 [23093944]	Long chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	NA	False	ACADL	False
rs3738934	KANSL1L	2	210886301	X-13431--nonanoylcarnitine*	211036019	Unknown		False	21	ACADL	acyl-CoA dehydrogenase, long chain	Cytoplasm	enzyme	X-13431--nonanoylcarnitine*	ACADL encodes Long-chain acyl-CoA dehydrogenase which has activity against a variety of medium and long chain acyl-CoAs [10832093].  X-13431 has been identified as nonaylcarnitine (C9:0) [23093944].  Acyl-CoAs and acyl-carnitines are readily interconverted.	ACADL	NA	NA	C9/C10:2 [20037589]; X-13431 [23093944]	Long chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	NA	False	ACADL	False
rs3738934	CERS6	2	169312372	X-13431--nonanoylcarnitine*	169631644	Metabolism, Environmental Information Processing	Lipid metabolism	True	21	ACADL	acyl-CoA dehydrogenase, long chain	Cytoplasm	enzyme	X-13431--nonanoylcarnitine*	ACADL encodes Long-chain acyl-CoA dehydrogenase which has activity against a variety of medium and long chain acyl-CoAs [10832093].  X-13431 has been identified as nonaylcarnitine (C9:0) [23093944].  Acyl-CoAs and acyl-carnitines are readily interconverted.	ACADL	NA	NA	C9/C10:2 [20037589]; X-13431 [23093944]	Long chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	NA	False	ACADL	False
rs3800993	RP11-122	7	141811549	1,5-anhydroglucitol (1,5-AG)	141922124	Unknown		False	64	MGAM	maltase-glucoamylase (alpha-glucosidase)	Plasma Membrane	enzyme	1,5-anhydroglucitol (1,5-AG)	1,5-AG is a marker for glycemic control [21085649]	unknown	NA	NA	NA	NA	DT	CHEMBL2074	Acarbose, Miglitol	NA	NA	NA	False	unknown	False
rs4073054	TOMM40L	1	161195793	X-10395	161200134	Human Diseases		False	12	NR1I3	nuclear receptor subfamily 1, group I, member 3	Nucleus	ligand-dependent nuclear receptor	X-10395	X-10395 is an unknown metabolite	unknown	NA	NA	NA	NA	DT, ME, is a modulator	CHEMBL5503	Meclizine is a modulator; Estradiol, Clotrimazoll are active; Phenobarbital is an indirect activator; Phenytoin is an indirect activator and Chlorpromazine is an inverse agonist	NA	NA	NA	False	unknown	False
rs4144027	XRCC3	14	104163946	asparagine	104181841	Genetic Information Processing		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	TDRD9	14	104394799	asparagine	104519004	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	LINC00637	14	104314058	asparagine	104324386	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	PPP1R13B	14	104200089	asparagine	104313927	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	CTD-2134	14	104320740	asparagine	104346448	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	APOPT1	14	104029299	asparagine	104073860	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	MARK3	14	103851729	asparagine	103970168	Unknown		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	KLC1	14	104028233	asparagine	104167888	Human Diseases		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4144027	HSP90AA1	14	102547075	asparagine	102605839	Genetic Information Processing, Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	105	ASPG	HEAT repeat containing 4	unknown	other	asparagine	ASPG encodes an asparaginase homolog which which can hydrolyse asparagine to form aspartic acid [9575212]	ASPG	KLC1-Skin,PPP1R13B-FAT,PPP1R13B-LCL,TRMT61A-LCL,XRCC3-LCL	NA	NA	NA	NA	NA	NA	NA	NA	KLC1 Skin PPP1R13B FAT PPP1R13B LCL TRMT61A LCL XRCC3 LCL	False	ASPG	False
rs4150581	GTF2H1	11	18343842	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	18388591	Genetic Information Processing, Human Diseases		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	HPS5	11	18300223	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	18343745	Unknown		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	LDHA	11	18415935	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	18429972	Metabolism, Environmental Information Processing, Organismal Systems, Human Diseases	Amino acid metabolism	True	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	MRGPRX3	11	18142502	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	18160027	Unknown		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	TSG101	11	18489883	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	18548779	Cellular Processes		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	DOCK10	2	225629807	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	225907162	Unknown		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4150581	COPB1	11	14464986	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	14521573	Unknown		False	87	HPS5	Hermansky-Pudlak syndrome 5	Cytoplasm	other	3-(4-hydroxyphenyl)lactate/ alpha-hydroxyisovalerate	Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a.	unknown	NA	NA	alpha-hydroxyisovalerate [21886157]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4253311	F11	4	187187099	bradykinin, des-arg(9)	187210835	Organismal Systems		False	39	KLKB1	kallikrein B, plasma (Fletcher factor) 1	Extracellular Space	peptidase	bradykinin, des-arg(9)	KLKB1 encodes kallikrein, a serine protease which releases bradykinin from kininogen [8662673]	KLKB1	CYP4V2-FAT,CYP4V2-LCL	Circulating vasoactive peptide levels [23381795]	bradykinin, des-arg(9) [21886157]; Metabolite levels [22916037]	NA	DT	CHEMBL2000	Ecallantine, Aprotinin	NA	NA	CYP4V2 FAT CYP4V2 LCL	False	KLKB1	False
rs4253311	FAM149A	4	187025573	bradykinin, des-arg(9)	187093821	Unknown		False	39	KLKB1	kallikrein B, plasma (Fletcher factor) 1	Extracellular Space	peptidase	bradykinin, des-arg(9)	KLKB1 encodes kallikrein, a serine protease which releases bradykinin from kininogen [8662673]	KLKB1	CYP4V2-FAT,CYP4V2-LCL	Circulating vasoactive peptide levels [23381795]	bradykinin, des-arg(9) [21886157]; Metabolite levels [22916037]	NA	DT	CHEMBL2000	Ecallantine, Aprotinin	NA	NA	CYP4V2 FAT CYP4V2 LCL	False	KLKB1	False
rs4253311	CYP4V2	4	187112674	bradykinin, des-arg(9)	187134610	Unknown		False	39	KLKB1	kallikrein B, plasma (Fletcher factor) 1	Extracellular Space	peptidase	bradykinin, des-arg(9)	KLKB1 encodes kallikrein, a serine protease which releases bradykinin from kininogen [8662673]	KLKB1	CYP4V2-FAT,CYP4V2-LCL	Circulating vasoactive peptide levels [23381795]	bradykinin, des-arg(9) [21886157]; Metabolite levels [22916037]	NA	DT	CHEMBL2000	Ecallantine, Aprotinin	NA	NA	CYP4V2 FAT CYP4V2 LCL	False	KLKB1	False
rs4253311	UFSP2	4	186320694	bradykinin, des-arg(9)	186347139	Unknown		False	39	KLKB1	kallikrein B, plasma (Fletcher factor) 1	Extracellular Space	peptidase	bradykinin, des-arg(9)	KLKB1 encodes kallikrein, a serine protease which releases bradykinin from kininogen [8662673]	KLKB1	CYP4V2-FAT,CYP4V2-LCL	Circulating vasoactive peptide levels [23381795]	bradykinin, des-arg(9) [21886157]; Metabolite levels [22916037]	NA	DT	CHEMBL2000	Ecallantine, Aprotinin	NA	NA	CYP4V2 FAT CYP4V2 LCL	False	KLKB1	False
rs4343	ACE	17	61554422	aspartylphenylalanine/ X-14450--phenylalanylleucine	61574981	Organismal Systems, Human Diseases		False	129	ACE	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Plasma Membrane	peptidase	aspartylphenylalanine/ X-14450--phenylalanylleucine	ACE encodes the angiotensin I converting enzyme (peptidyldipeptidase A) 1.  Aspartylphenylalanine is a dipeptide closely related to aspartame. Ratio interpretation: both molecules are dipeptides which may each be products or one may be normalizing the dipeptide pool for the other.  X-14450 is phenylalanylleucine (possible 'selectivity')	ACE	FTSJ3-FAT	Angiotensin-converting enzyme activity [20066004]	aspartylphenylalanine [21886157]; Metabolite levels [23281178]	NA	DT	CHEMBL1808	Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Spirapril, Trandolapril	2	126	FTSJ3 FAT	False	ACE	True
rs4343	FTSJ3	17	61896793	aspartylphenylalanine/ X-14450--phenylalanylleucine	61907372	Unknown		False	129	ACE	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Plasma Membrane	peptidase	aspartylphenylalanine/ X-14450--phenylalanylleucine	ACE encodes the angiotensin I converting enzyme (peptidyldipeptidase A) 1.  Aspartylphenylalanine is a dipeptide closely related to aspartame. Ratio interpretation: both molecules are dipeptides which may each be products or one may be normalizing the dipeptide pool for the other.  X-14450 is phenylalanylleucine (possible 'selectivity')	ACE	FTSJ3-FAT	Angiotensin-converting enzyme activity [20066004]	aspartylphenylalanine [21886157]; Metabolite levels [23281178]	NA	DT	CHEMBL1808	Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Spirapril, Trandolapril	2	126	FTSJ3 FAT	False	ACE	False
rs4343	PSMC5	17	61905032	aspartylphenylalanine/ X-14450--phenylalanylleucine	61909379	Genetic Information Processing, Human Diseases		False	129	ACE	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Plasma Membrane	peptidase	aspartylphenylalanine/ X-14450--phenylalanylleucine	ACE encodes the angiotensin I converting enzyme (peptidyldipeptidase A) 1.  Aspartylphenylalanine is a dipeptide closely related to aspartame. Ratio interpretation: both molecules are dipeptides which may each be products or one may be normalizing the dipeptide pool for the other.  X-14450 is phenylalanylleucine (possible 'selectivity')	ACE	FTSJ3-FAT	Angiotensin-converting enzyme activity [20066004]	aspartylphenylalanine [21886157]; Metabolite levels [23281178]	NA	DT	CHEMBL1808	Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Spirapril, Trandolapril	2	126	FTSJ3 FAT	False	ACE	False
rs4343	KCNH6	17	61600695	aspartylphenylalanine/ X-14450--phenylalanylleucine	61626338	Unknown		False	129	ACE	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Plasma Membrane	peptidase	aspartylphenylalanine/ X-14450--phenylalanylleucine	ACE encodes the angiotensin I converting enzyme (peptidyldipeptidase A) 1.  Aspartylphenylalanine is a dipeptide closely related to aspartame. Ratio interpretation: both molecules are dipeptides which may each be products or one may be normalizing the dipeptide pool for the other.  X-14450 is phenylalanylleucine (possible 'selectivity')	ACE	FTSJ3-FAT	Angiotensin-converting enzyme activity [20066004]	aspartylphenylalanine [21886157]; Metabolite levels [23281178]	NA	DT	CHEMBL1808	Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Spirapril, Trandolapril	2	126	FTSJ3 FAT	False	ACE	False
rs4343	DCAF7	17	61627822	aspartylphenylalanine/ X-14450--phenylalanylleucine	61671639	Unknown		False	129	ACE	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Plasma Membrane	peptidase	aspartylphenylalanine/ X-14450--phenylalanylleucine	ACE encodes the angiotensin I converting enzyme (peptidyldipeptidase A) 1.  Aspartylphenylalanine is a dipeptide closely related to aspartame. Ratio interpretation: both molecules are dipeptides which may each be products or one may be normalizing the dipeptide pool for the other.  X-14450 is phenylalanylleucine (possible 'selectivity')	ACE	FTSJ3-FAT	Angiotensin-converting enzyme activity [20066004]	aspartylphenylalanine [21886157]; Metabolite levels [23281178]	NA	DT	CHEMBL1808	Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Spirapril, Trandolapril	2	126	FTSJ3 FAT	False	ACE	False
rs445925	BCAM	19	45312328	X-11820/ cholesterol	45324671	Unknown		False	135	APOE	apolipoprotein E	Extracellular Space	transporter	X-11820/ cholesterol	APOE|APOC1|APOC2 locus has been associated with LDL, HDL and total cholesterol levels in previous GWAS [20686565]. Ratio interpretation: n/a.	APOE|APOC1|APOC2	APOE-FAT,APOE-Skin,APOC2-LCL	Apolipoprotein Levels [23031429]; Cardiovascular disease risk factors [20838585]; Carotid intima media thickness [21909108]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]	Metabolite levels [22916037]	Hyperlipidemia type 3	NA	NA	NA	2	15	APOE FAT APOE Skin APOC2 LCL	True	APOE APOC1 APOC2	False
rs445925	APOE	19	45409011	X-11820/ cholesterol	45412650	Organismal Systems		False	135	APOE	apolipoprotein E	Extracellular Space	transporter	X-11820/ cholesterol	APOE|APOC1|APOC2 locus has been associated with LDL, HDL and total cholesterol levels in previous GWAS [20686565]. Ratio interpretation: n/a.	APOE|APOC1|APOC2	APOE-FAT,APOE-Skin,APOC2-LCL	Apolipoprotein Levels [23031429]; Cardiovascular disease risk factors [20838585]; Carotid intima media thickness [21909108]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]	Metabolite levels [22916037]	Hyperlipidemia type 3	NA	NA	NA	2	15	APOE FAT APOE Skin APOC2 LCL	True	APOE APOC1 APOC2	True
rs445925	RYR1	19	38924339	X-11820/ cholesterol	39078204	Environmental Information Processing, Organismal Systems		False	135	APOE	apolipoprotein E	Extracellular Space	transporter	X-11820/ cholesterol	APOE|APOC1|APOC2 locus has been associated with LDL, HDL and total cholesterol levels in previous GWAS [20686565]. Ratio interpretation: n/a.	APOE|APOC1|APOC2	APOE-FAT,APOE-Skin,APOC2-LCL	Apolipoprotein Levels [23031429]; Cardiovascular disease risk factors [20838585]; Carotid intima media thickness [21909108]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]	Metabolite levels [22916037]	Hyperlipidemia type 3	NA	NA	NA	2	15	APOE FAT APOE Skin APOC2 LCL	True	APOE APOC1 APOC2	False
rs445925	RERE	1	8412457	X-11820/ cholesterol	8877702	Unknown		False	135	APOE	apolipoprotein E	Extracellular Space	transporter	X-11820/ cholesterol	APOE|APOC1|APOC2 locus has been associated with LDL, HDL and total cholesterol levels in previous GWAS [20686565]. Ratio interpretation: n/a.	APOE|APOC1|APOC2	APOE-FAT,APOE-Skin,APOC2-LCL	Apolipoprotein Levels [23031429]; Cardiovascular disease risk factors [20838585]; Carotid intima media thickness [21909108]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]	Metabolite levels [22916037]	Hyperlipidemia type 3	NA	NA	NA	2	15	APOE FAT APOE Skin APOC2 LCL	True	APOE APOC1 APOC2	False
rs4488133	HPS1	10	100175955	X-12092	100206684	Unknown		False	84	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	unknown	other	X-12092	PYROXD2 was shown to associate with plasma dimethylamine levels in a previous GWAS [21931564]	PYROXD2	NA	NA	X-12092, X-12093 [23093944]; TMAu [21931564]; Asymmetric dimethylarginine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	PYROXD2	False
rs4488133	PYROXD2	10	100143322	X-12092	100174941	Unknown		False	84	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	unknown	other	X-12092	PYROXD2 was shown to associate with plasma dimethylamine levels in a previous GWAS [21931564]	PYROXD2	NA	NA	X-12092, X-12093 [23093944]; TMAu [21931564]; Asymmetric dimethylarginine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	PYROXD2	True
rs4488133	SFRP5	10	99526508	X-12092	99531709	Environmental Information Processing		False	84	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	unknown	other	X-12092	PYROXD2 was shown to associate with plasma dimethylamine levels in a previous GWAS [21931564]	PYROXD2	NA	NA	X-12092, X-12093 [23093944]; TMAu [21931564]; Asymmetric dimethylarginine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	PYROXD2	False
rs4488133	FAM53B	10	126307861	X-12092	126432838	Unknown		False	84	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	unknown	other	X-12092	PYROXD2 was shown to associate with plasma dimethylamine levels in a previous GWAS [21931564]	PYROXD2	NA	NA	X-12092, X-12093 [23093944]; TMAu [21931564]; Asymmetric dimethylarginine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	PYROXD2	False
rs4625783	AC132872.2	17	80214131	3-(4-hydroxyphenyl)lactate	80216080	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	CCDC57	17	80059336	3-(4-hydroxyphenyl)lactate	80170706	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	GCGR	17	79762010	3-(4-hydroxyphenyl)lactate	79771889	Environmental Information Processing, Organismal Systems		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	LRRC45	17	79981178	3-(4-hydroxyphenyl)lactate	79989027	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	ASPSCR1	17	79934683	3-(4-hydroxyphenyl)lactate	79975282	Human Diseases		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	DCXR	17	79993012	3-(4-hydroxyphenyl)lactate	79995608	Metabolism	Carbohydrate metabolism	True	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	FASN	17	80036214	3-(4-hydroxyphenyl)lactate	80056208	Metabolism, Environmental Information Processing, Organismal Systems	Lipid metabolism	True	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	RAC3	17	79989500	3-(4-hydroxyphenyl)lactate	79992078	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	SLC16A3	17	80186273	3-(4-hydroxyphenyl)lactate	80219005	Human Diseases		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	RP11-137	17	80117932	3-(4-hydroxyphenyl)lactate	80118328	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	GPS1	17	80008641	3-(4-hydroxyphenyl)lactate	80015346	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	DUS1L	17	80015382	3-(4-hydroxyphenyl)lactate	80023763	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	PTDSS2	11	448268	3-(4-hydroxyphenyl)lactate	491387	Metabolism	Lipid metabolism	True	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4625783	ZNF346	5	176449697	3-(4-hydroxyphenyl)lactate	176508190	Unknown		False	130	CCDC57	coiled-coil domain containing 57	unknown	other	3-(4-hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate is derived from tyrosine metabolism	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs4675874	C2orf54	2	241825465	X-12556	241836306	Unknown		False	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4675874	AGXT	2	241807896	X-12556	241818537	Metabolism, Cellular Processes	Amino acid metabolism	True	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4675874	SNED1	2	241938255	X-12556	242034011	Unknown		False	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4675874	AC104809.4	2	241894034	X-12556	241906848	Unknown		False	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4675874	AC104809.3	2	241858202	X-12556	241932728	Unknown		False	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4675874	AC005237.4	2	241955016	X-12556	241973020	Unknown		False	24	AGXT	alanine-glyoxylate aminotransferase	Cytoplasm	enzyme	X-12556	X-12556 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	False	unknown	False
rs4680	ARVCF	22	19957499	X-11593--O-methylascorbate*	20004331	Unknown		False	142	COMT	catechol-O-methyltransferase	Cytoplasm	enzyme	X-11593--O-methylascorbate*	COMT encodes catechol-O-methyltransferase, which can methylate ascorbic acid to form O-methylascorbate [7129800].  X-11593 was experimentally identified to be O-methylascorbate [23093944]	COMT	ZDHHC8-LCL	NA	X-11593,X-01911 [23093944]	NA	DT, ME	CHEMBL2023	Substrates: Levodopa; Inhibitors: Entacapone, Tolcapone	5	6	ZDHHC8 LCL	False	COMT	False
rs4680	COMT	22	19929130	X-11593--O-methylascorbate*	19957418	Metabolism, Organismal Systems	Amino acid metabolism	True	142	COMT	catechol-O-methyltransferase	Cytoplasm	enzyme	X-11593--O-methylascorbate*	COMT encodes catechol-O-methyltransferase, which can methylate ascorbic acid to form O-methylascorbate [7129800].  X-11593 was experimentally identified to be O-methylascorbate [23093944]	COMT	ZDHHC8-LCL	NA	X-11593,X-01911 [23093944]	NA	DT, ME	CHEMBL2023	Substrates: Levodopa; Inhibitors: Entacapone, Tolcapone	5	6	ZDHHC8 LCL	False	COMT	True
rs4680	RP3-400N	22	31688521	X-11593--O-methylascorbate*	31734007	Unknown		False	142	COMT	catechol-O-methyltransferase	Cytoplasm	enzyme	X-11593--O-methylascorbate*	COMT encodes catechol-O-methyltransferase, which can methylate ascorbic acid to form O-methylascorbate [7129800].  X-11593 was experimentally identified to be O-methylascorbate [23093944]	COMT	ZDHHC8-LCL	NA	X-11593,X-01911 [23093944]	NA	DT, ME	CHEMBL2023	Substrates: Levodopa; Inhibitors: Entacapone, Tolcapone	5	6	ZDHHC8 LCL	False	COMT	False
rs4680	ZFPM1	16	88519725	X-11593--O-methylascorbate*	88603424	Unknown		False	142	COMT	catechol-O-methyltransferase	Cytoplasm	enzyme	X-11593--O-methylascorbate*	COMT encodes catechol-O-methyltransferase, which can methylate ascorbic acid to form O-methylascorbate [7129800].  X-11593 was experimentally identified to be O-methylascorbate [23093944]	COMT	ZDHHC8-LCL	NA	X-11593,X-01911 [23093944]	NA	DT, ME	CHEMBL2023	Substrates: Levodopa; Inhibitors: Entacapone, Tolcapone	5	6	ZDHHC8 LCL	False	COMT	False
rs4687717	TKT	3	53258723	phosphate/ erythronate	53290047	Metabolism	Carbohydrate metabolism	True	27	TKT	transketolase	Cytoplasm	enzyme	phosphate/ erythronate	TKT encodes a transketolase which can take D-Erythrose 4-phosphate as a substrate [9924800]. Ratio interpretation:  TKT can take D-erythrose 4-phosphate as a substrate  'normalizing').  Plasma concentrations of the erythronate and phosphate may thus reflect cellular concentrations of the substrate.	TKT	PRKCD-Skin	NA	NA	NA	NA	CHEMBL4983	Compounds with activity in ChEMBL	NA	2	PRKCD Skin	False	TKT	True
rs4687717	ITIH4	3	52846991	phosphate/ erythronate	52864755	Unknown		False	27	TKT	transketolase	Cytoplasm	enzyme	phosphate/ erythronate	TKT encodes a transketolase which can take D-Erythrose 4-phosphate as a substrate [9924800]. Ratio interpretation:  TKT can take D-erythrose 4-phosphate as a substrate  'normalizing').  Plasma concentrations of the erythronate and phosphate may thus reflect cellular concentrations of the substrate.	TKT	PRKCD-Skin	NA	NA	NA	NA	CHEMBL4983	Compounds with activity in ChEMBL	NA	2	PRKCD Skin	False	TKT	False
rs4687717	PRKCD	3	53190025	phosphate/ erythronate	53226733	Cellular Processes, Organismal Systems, Human Diseases		False	27	TKT	transketolase	Cytoplasm	enzyme	phosphate/ erythronate	TKT encodes a transketolase which can take D-Erythrose 4-phosphate as a substrate [9924800]. Ratio interpretation:  TKT can take D-erythrose 4-phosphate as a substrate  'normalizing').  Plasma concentrations of the erythronate and phosphate may thus reflect cellular concentrations of the substrate.	TKT	PRKCD-Skin	NA	NA	NA	NA	CHEMBL4983	Compounds with activity in ChEMBL	NA	2	PRKCD Skin	False	TKT	False
rs4690909	PPID	4	159630776	octanoylcarnitine/ X-13435	159644548	Cellular Processes		False	38	ETFDH	electron-transferring-flavoprotein dehydrogenase	Cytoplasm	enzyme	octanoylcarnitine/ X-13435	ETFDH encodes a mitochondrial electron transfer flavoprotein dehydrogenase which is essential for electron transfer from the short-, medium- and long-chain acyl-CoA dehydrogenases.  Mutations in ETFDH lead to multiple acyl-CoA dehydrogenase deficiency, which is characterized by elevated short-, medium- and long-chain acyl carnitines [17412732].  Ratio interpretation:  octanoylcarnitine is a substrate.  X-13435 is most probably a 10:1 carnitine and may normalize for the medium chain length carnitine pool (possible 'normalizing')	ETFDH	ETFDH-FAT,ETFDH-LCL,ETFDH-Skin	NA	decanoylcarnitine [21886157]; C14:1-OH/C10 [20037589]	Glutaric acidemia type II	NA	NA	NA	NA	NA	ETFDH FAT ETFDH LCL ETFDH Skin	True	ETFDH	False
rs4690909	ETFDH	4	159593408	octanoylcarnitine/ X-13435	159630285	Unknown		False	38	ETFDH	electron-transferring-flavoprotein dehydrogenase	Cytoplasm	enzyme	octanoylcarnitine/ X-13435	ETFDH encodes a mitochondrial electron transfer flavoprotein dehydrogenase which is essential for electron transfer from the short-, medium- and long-chain acyl-CoA dehydrogenases.  Mutations in ETFDH lead to multiple acyl-CoA dehydrogenase deficiency, which is characterized by elevated short-, medium- and long-chain acyl carnitines [17412732].  Ratio interpretation:  octanoylcarnitine is a substrate.  X-13435 is most probably a 10:1 carnitine and may normalize for the medium chain length carnitine pool (possible 'normalizing')	ETFDH	ETFDH-FAT,ETFDH-LCL,ETFDH-Skin	NA	decanoylcarnitine [21886157]; C14:1-OH/C10 [20037589]	Glutaric acidemia type II	NA	NA	NA	NA	NA	ETFDH FAT ETFDH LCL ETFDH Skin	True	ETFDH	True
rs4784054	SLC38A7	16	58699013	phenyllactate (PLA)	58719008	Unknown		False	121	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate.	GOT2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	GOT2	False
rs4784054	GOT2	16	58741035	phenyllactate (PLA)	58768261	Metabolism, Organismal Systems	Amino acid metabolism	True	121	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate.	GOT2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	GOT2	True
rs4784054	RP11-410	16	58767816	phenyllactate (PLA)	59142878	Unknown		False	121	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)	Cytoplasm	enzyme	phenyllactate (PLA)	GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates.  [4623131].  In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate.	GOT2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	GOT2	False
rs4787294	AC008731.1	16	24931582	scyllo-inositol	24932325	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	False
rs4787294	SLC5A11	16	24857162	scyllo-inositol	24922949	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	True
rs4787294	RP11-266	16	25043202	scyllo-inositol	25069430	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	False
rs4787294	RP11-266	16	25151898	scyllo-inositol	25160353	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	False
rs4787294	RP11-266	16	25082811	scyllo-inositol	25084048	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	False
rs4787294	C16orf52	16	22018959	scyllo-inositol	22098855	Unknown		False	119	SLC5A11	solute carrier family 5 (sodium/glucose cotransporter), member 11	Plasma Membrane	transporter	scyllo-inositol	SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366]	SLC5A11	SLC5A11-FAT	NA	NA	NA	NA	CHEMBL1744524	Compounds with low activity in ChEMBL	NA	NA	SLC5A11 FAT	True	SLC5A11	False
rs4808136	ELL	19	18553473	myo-inositol	18632937	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4808136	SSBP4	19	18529674	myo-inositol	18545197	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4808136	LRRC25	19	18501954	myo-inositol	18508427	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4808136	ISYNA1	19	18545373	myo-inositol	18549111	Metabolism	Carbohydrate metabolism	True	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	True
rs4808136	CRLF1	19	18683418	myo-inositol	18718551	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4808136	PGPEP1	19	18451397	myo-inositol	18480760	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4808136	SLBP	4	1694527	myo-inositol	1714282	Unknown		False	133	ISYNA1	inositol-3-phosphate synthase 1	unknown	enzyme	myo-inositol	ISYNA1 encodes myo-inositol-1-phosphate synthase which converts d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate [15024000]	ISYNA1	ELL-FAT,ELL-LCL,ELL-Skin,UBA52-Skin	NA	NA	NA	NA	NA	NA	NA	NA	ELL FAT ELL LCL ELL Skin UBA52 Skin	False	ISYNA1	False
rs4814176	SPTLC3	20	12989627	X-10510/ palmitoyl sphingomyelin	13147411	Metabolism, Environmental Information Processing	Lipid metabolism	True	139	SPTLC3	serine palmitoyltransferase, long chain base subunit 3	Cytoplasm	enzyme	X-10510/ palmitoyl sphingomyelin	SPTLC3 encodes a subunit of serine palmitoyltransferase [17023427].  SPT is the first step in de novo sphingolipid biosynthesis. Ratio interpretation: n/a.	SPTLC3	SPTLC3-LIVER	NA	Sphingolipid levels [22359512,19798445]; SM (OH) C24:1/SM C16:0 [20037589]	NA	NA	NA	NA	NA	NA	SPTLC3 LIVER	True	SPTLC3	True
rs493519	WDR66	12	122356204	2-hydroxyisobutyrate	122441833	Unknown		False	100	WDR66	acyl-CoA dehydrogenase, C-2 to C-3 short chain	Cytoplasm	enzyme	2-hydroxyisobutyrate	2-hydroxyisobutyrate may be related to certain branched chain amino acid degradation metabolites	unknown	NA	NA	Urinary metabolites [21572414]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs493519	PSMD9	12	122326637	2-hydroxyisobutyrate	122355767	Unknown		False	100	WDR66	acyl-CoA dehydrogenase, C-2 to C-3 short chain	Cytoplasm	enzyme	2-hydroxyisobutyrate	2-hydroxyisobutyrate may be related to certain branched chain amino acid degradation metabolites	unknown	NA	NA	Urinary metabolites [21572414]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs493519	STX2	12	131274145	2-hydroxyisobutyrate	131323811	Genetic Information Processing, Organismal Systems		False	100	WDR66	acyl-CoA dehydrogenase, C-2 to C-3 short chain	Cytoplasm	enzyme	2-hydroxyisobutyrate	2-hydroxyisobutyrate may be related to certain branched chain amino acid degradation metabolites	unknown	NA	NA	Urinary metabolites [21572414]	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs494562	NT5E	6	86159809	inosine	86205500	Metabolism	Metabolism of cofactors and vitamins	True	52	NT5E	5'-nucleotidase, ecto (CD73)	Plasma Membrane	phosphatase	inosine	NT5E encodes an ecto 5'-nucleotidase which can generate inosine as a product [6271180].	NT5E	NT5E-LCL	NA	inosine [21886157]	NA	NA	CHEMBL5957	Compounds with inhibitory activity in ChEMBL	NA	NA	NT5E LCL	True	NT5E	True
rs494562	RP11-30P	6	86096937	inosine	86099904	Unknown		False	52	NT5E	5'-nucleotidase, ecto (CD73)	Plasma Membrane	phosphatase	inosine	NT5E encodes an ecto 5'-nucleotidase which can generate inosine as a product [6271180].	NT5E	NT5E-LCL	NA	inosine [21886157]	NA	NA	CHEMBL5957	Compounds with inhibitory activity in ChEMBL	NA	NA	NT5E LCL	True	NT5E	False
rs494562	KCNQ5	6	73331520	inosine	73908574	Organismal Systems		False	52	NT5E	5'-nucleotidase, ecto (CD73)	Plasma Membrane	phosphatase	inosine	NT5E encodes an ecto 5'-nucleotidase which can generate inosine as a product [6271180].	NT5E	NT5E-LCL	NA	inosine [21886157]	NA	NA	CHEMBL5957	Compounds with inhibitory activity in ChEMBL	NA	NA	NT5E LCL	True	NT5E	False
rs4947534	SUMF2	7	56131695	serine	56148363	Unknown		False	59	PSPH	phosphoserine phosphatase	Cytoplasm	phosphatase	serine	PSPH encodes a phosphoserine phosphatase which generates serine [16589713]	PSPH	NA	NA	NA	3-Phosphoserine phosphatase deficiency	NA	NA	NA	NA	NA	NA	False	PSPH	False
rs4947534	CCT6A	7	56119323	serine	56131682	Unknown		False	59	PSPH	phosphoserine phosphatase	Cytoplasm	phosphatase	serine	PSPH encodes a phosphoserine phosphatase which generates serine [16589713]	PSPH	NA	NA	NA	3-Phosphoserine phosphatase deficiency	NA	NA	NA	NA	NA	NA	False	PSPH	False
rs4947534	ZNF713	7	55955205	serine	56009918	Unknown		False	59	PSPH	phosphoserine phosphatase	Cytoplasm	phosphatase	serine	PSPH encodes a phosphoserine phosphatase which generates serine [16589713]	PSPH	NA	NA	NA	3-Phosphoserine phosphatase deficiency	NA	NA	NA	NA	NA	NA	False	PSPH	False
rs4947534	GBAS	7	56019486	serine	56067874	Unknown		False	59	PSPH	phosphoserine phosphatase	Cytoplasm	phosphatase	serine	PSPH encodes a phosphoserine phosphatase which generates serine [16589713]	PSPH	NA	NA	NA	3-Phosphoserine phosphatase deficiency	NA	NA	NA	NA	NA	NA	False	PSPH	False
rs4949874	ACADM	1	76190036	Acetylcarnitine/ hexanoylcarnitine	76251878	Metabolism, Organismal Systems	Amino acid metabolism	True	7	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	Cytoplasm	enzyme	Acetylcarnitine/ hexanoylcarnitine	ACADM encodes a medium-chain specific acyl-CoA dehydrogenase with activity against a range of acyl-CoAs with chain lengths from 4 to 16 carbons.  Peak activity was reported for hexanoyl-CoA [3597357].  The acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: related to substrate and product ('activity').  ACADM acts on hexanoyl-CoA (interconverts with hexanoylcarnitine) and an end product of fatty acid degradation is acetyl-CoA (interconverts with acetylcarnitine)	ACADM	MSH4-LCL	NA	hexanoylcarnitine/oleate (18:1n9) [21886157]; C12/C10 [20037589]	Medium chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	MSH4 LCL	False	ACADM	True
rs4949874	MSH4	1	76262567	Acetylcarnitine/ hexanoylcarnitine	76378923	Unknown		False	7	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	Cytoplasm	enzyme	Acetylcarnitine/ hexanoylcarnitine	ACADM encodes a medium-chain specific acyl-CoA dehydrogenase with activity against a range of acyl-CoAs with chain lengths from 4 to 16 carbons.  Peak activity was reported for hexanoyl-CoA [3597357].  The acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: related to substrate and product ('activity').  ACADM acts on hexanoyl-CoA (interconverts with hexanoylcarnitine) and an end product of fatty acid degradation is acetyl-CoA (interconverts with acetylcarnitine)	ACADM	MSH4-LCL	NA	hexanoylcarnitine/oleate (18:1n9) [21886157]; C12/C10 [20037589]	Medium chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	MSH4 LCL	False	ACADM	False
rs4949874	PGM1	1	64058947	Acetylcarnitine/ hexanoylcarnitine	64125916	Metabolism	Nucleotide metabolism	True	7	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	Cytoplasm	enzyme	Acetylcarnitine/ hexanoylcarnitine	ACADM encodes a medium-chain specific acyl-CoA dehydrogenase with activity against a range of acyl-CoAs with chain lengths from 4 to 16 carbons.  Peak activity was reported for hexanoyl-CoA [3597357].  The acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: related to substrate and product ('activity').  ACADM acts on hexanoyl-CoA (interconverts with hexanoylcarnitine) and an end product of fatty acid degradation is acetyl-CoA (interconverts with acetylcarnitine)	ACADM	MSH4-LCL	NA	hexanoylcarnitine/oleate (18:1n9) [21886157]; C12/C10 [20037589]	Medium chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	MSH4 LCL	False	ACADM	False
rs4949874	FAM69A	1	93307724	Acetylcarnitine/ hexanoylcarnitine	93427057	Unknown		False	7	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	Cytoplasm	enzyme	Acetylcarnitine/ hexanoylcarnitine	ACADM encodes a medium-chain specific acyl-CoA dehydrogenase with activity against a range of acyl-CoAs with chain lengths from 4 to 16 carbons.  Peak activity was reported for hexanoyl-CoA [3597357].  The acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: related to substrate and product ('activity').  ACADM acts on hexanoyl-CoA (interconverts with hexanoylcarnitine) and an end product of fatty acid degradation is acetyl-CoA (interconverts with acetylcarnitine)	ACADM	MSH4-LCL	NA	hexanoylcarnitine/oleate (18:1n9) [21886157]; C12/C10 [20037589]	Medium chain acyl-CoA dehydrogenase deficiency	NA	NA	NA	NA	NA	MSH4 LCL	False	ACADM	False
rs4986894	MTND4P19	10	96533913	X-14473	96534390	Unknown		False	79	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-14473	CYP2C9 encodes a Cytochrome P450 which has activity against arachidonic acid [7625847].	CYP2C9	NA	Acenocoumarol maintenance dosage [19578179]; Response to clopidogrel therapy [19706858]	NA	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	CYP2C9	False
rs4986894	CYP2C19	10	96522381	X-14473	96613017	Metabolism, Organismal Systems, Human Diseases	Xenobiotics biodegradation and metabolism	True	79	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-14473	CYP2C9 encodes a Cytochrome P450 which has activity against arachidonic acid [7625847].	CYP2C9	NA	Acenocoumarol maintenance dosage [19578179]; Response to clopidogrel therapy [19706858]	NA	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	CYP2C9	False
rs4986894	HELLS	10	96305547	X-14473	96373662	Unknown		False	79	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9	Cytoplasm	enzyme	X-14473	CYP2C9 encodes a Cytochrome P450 which has activity against arachidonic acid [7625847].	CYP2C9	NA	Acenocoumarol maintenance dosage [19578179]; Response to clopidogrel therapy [19706858]	NA	NA	ME	CHEMBL3397	Substrates: NSAIDs (e.g. diclofenac, celecoxib, ibuprofen, flurbiprofen, naproxen, piroxi- cam, mefenamic acid, and suprofen), oral hypoglycemics (e.g., glyburide, glipizide, glimepiride, tolbutamide), oral anticoagulants (e.g., S-warfarin, S-acenocoumarol, and phenprocoumon), diuretics and uricosurics (e.g., sulfinpyrazone sulfide, torsemide, tienilic acid ticrynafen), angiotensin II blockers (e.g., candesartan, irbesartan, losartan), anticonvulsants (e.g., phenytoin), and many others; Inhibitors: Tienilic acid, benzbromarone and 2-methyl- 3-(3',5'-diiodo-4'-hydroxybenzoyl)benzoflura, amiodarone, capecitabine, fluconazole, fluoxetine, fluvoxamine, oxandrolone, sulfaphenazole, sulfinpyrazone	NA	NA	NA	False	CYP2C9	False
rs499368	RP11-283	12	312808	betaine	314189	Unknown		False	92	SLC6A12	zinc finger protein 259	Nucleus	other	betaine	SLC6A12 is a betaine transporter [8198549]	SLC6A12	NA	NA	Metabolite levels [23378610]	NA	NA	CHEMBL3715	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A12	False
rs499368	RP11-598	12	276022	betaine	291565	Unknown		False	92	SLC6A12	zinc finger protein 259	Nucleus	other	betaine	SLC6A12 is a betaine transporter [8198549]	SLC6A12	NA	NA	Metabolite levels [23378610]	NA	NA	CHEMBL3715	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A12	False
rs499368	SLC6A12	12	299243	betaine	323689	Organismal Systems		False	92	SLC6A12	zinc finger protein 259	Nucleus	other	betaine	SLC6A12 is a betaine transporter [8198549]	SLC6A12	NA	NA	Metabolite levels [23378610]	NA	NA	CHEMBL3715	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A12	True
rs5030062	LPP	3	187925986	bradykinin, des-arg(9)	188608460	Unknown		False	31	KNG1	kininogen 1	Extracellular Space	other	bradykinin, des-arg(9)	KNG1 includes the coding sequence for the bradykinin peptide [2989293]	KNG1	NA	Activated partial thromboplastin time [20303064,22703881]	NA	NA	NA	NA	NA	NA	2	NA	False	KNG1	False
rs5030062	DNAJC13	3	132136370	bradykinin, des-arg(9)	132257876	Unknown		False	31	KNG1	kininogen 1	Extracellular Space	other	bradykinin, des-arg(9)	KNG1 includes the coding sequence for the bradykinin peptide [2989293]	KNG1	NA	Activated partial thromboplastin time [20303064,22703881]	NA	NA	NA	NA	NA	NA	2	NA	False	KNG1	False
rs559555	SPAST	2	32288680	X-11444/ X-12844	32382706	Unknown		False	16	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)	Cytoplasm	enzyme	X-11444/ X-12844	SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a.	SRD5A2	NA	NA	NA	NA	DT	CHEMBL1856	Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)	2	9	NA	False	SRD5A2	False
rs559555	SLC30A6	2	32390933	X-11444/ X-12844	32449448	Unknown		False	16	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)	Cytoplasm	enzyme	X-11444/ X-12844	SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a.	SRD5A2	NA	NA	NA	NA	DT	CHEMBL1856	Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)	2	9	NA	False	SRD5A2	False
rs559555	NLRC4	2	32449522	X-11444/ X-12844	32490923	Organismal Systems, Human Diseases		False	16	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)	Cytoplasm	enzyme	X-11444/ X-12844	SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a.	SRD5A2	NA	NA	NA	NA	DT	CHEMBL1856	Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)	2	9	NA	False	SRD5A2	False
rs559555	XDH	2	31557187	X-11444/ X-12844	31637581	Metabolism, Cellular Processes	Xenobiotics biodegradation and metabolism	True	16	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)	Cytoplasm	enzyme	X-11444/ X-12844	SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a.	SRD5A2	NA	NA	NA	NA	DT	CHEMBL1856	Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)	2	9	NA	False	SRD5A2	False
rs559555	MYT1L	2	1792885	X-11444/ X-12844	2335032	Unknown		False	16	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)	Cytoplasm	enzyme	X-11444/ X-12844	SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme which converts testosterone into dihydrotestosterone [1505484]. X-11444 and X-12844 are most likely steroid molecules. Ratio interpretation: n/a.	SRD5A2	NA	NA	NA	NA	DT	CHEMBL1856	Finasteride (specific), dutasteride (non-specific for this isoform), azelic acid (has shown inibitory acivity towards this target)	2	9	NA	False	SRD5A2	False
rs56322409	ENTPD1	10	97471536	citrulline	97637023	Metabolism, Human Diseases	Nucleotide metabolism	True	83	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	Cytoplasm	kinase	citrulline	ALDH18A1 encodes delta-1-pyrroline-5-carboxylate synthetase which catalyzes a step in the de novo production of ornithine which is subsequently converted to citrulline.  Mutations in ALDH18A1 can result in hypocitrullinemia [11092761].	ALDH18A1	ALDH18A1-FAT,CC2D2B-LCL,ENTPD1-LCL	NA	NA	ALDH18A1-related DeBarsy syndrome	ME	NA	No specific drug is primarily metabolised by this enzyme	NA	NA	ALDH18A1 FAT CC2D2B LCL ENTPD1 LCL	True	ALDH18A1	False
rs56322409	TCTN3	10	97423158	citrulline	97453900	Unknown		False	83	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	Cytoplasm	kinase	citrulline	ALDH18A1 encodes delta-1-pyrroline-5-carboxylate synthetase which catalyzes a step in the de novo production of ornithine which is subsequently converted to citrulline.  Mutations in ALDH18A1 can result in hypocitrullinemia [11092761].	ALDH18A1	ALDH18A1-FAT,CC2D2B-LCL,ENTPD1-LCL	NA	NA	ALDH18A1-related DeBarsy syndrome	ME	NA	No specific drug is primarily metabolised by this enzyme	NA	NA	ALDH18A1 FAT CC2D2B LCL ENTPD1 LCL	True	ALDH18A1	False
rs56322409	ALDH18A1	10	97365696	citrulline	97416463	Metabolism	Amino acid metabolism	True	83	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	Cytoplasm	kinase	citrulline	ALDH18A1 encodes delta-1-pyrroline-5-carboxylate synthetase which catalyzes a step in the de novo production of ornithine which is subsequently converted to citrulline.  Mutations in ALDH18A1 can result in hypocitrullinemia [11092761].	ALDH18A1	ALDH18A1-FAT,CC2D2B-LCL,ENTPD1-LCL	NA	NA	ALDH18A1-related DeBarsy syndrome	ME	NA	No specific drug is primarily metabolised by this enzyme	NA	NA	ALDH18A1 FAT CC2D2B LCL ENTPD1 LCL	True	ALDH18A1	True
rs601338	SEC1P	19	49141402	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49184461	Unknown		False	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	False
rs601338	NTN5	19	49164664	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49176338	Unknown		False	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	False
rs601338	FUT2	19	49199228	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49209207	Metabolism	Carbohydrate metabolism	True	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	True
rs601338	MAMSTR	19	49215999	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49222978	Unknown		False	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	False
rs601338	RASIP1	19	49223844	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49243978	Unknown		False	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	False
rs601338	FAM83E	19	49104067	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	49118111	Unknown		False	137	FUT2	fucosyltransferase 2 (secretor status included)	Cytoplasm	enzyme	ADSGEGDFXAEGGGVR/ ADpSGEGDFXAEGGGVR	FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235].  FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair.  ALPL plausibly affects phosphorylation state of fibrinogen ('activity')	FUT2	FUT2-Skin,NTN5-Skin,RASIP1-Skin,SULT2B1-FAT	Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911]	ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157]	NA	NA	NA	NA	NA	NA	FUT2 Skin NTN5 Skin RASIP1 Skin SULT2B1 FAT	True	FUT2	False
rs603424	BLOC1S2	10	102033713	myristate (14:0)/ myristoleate (14:1n5)	102046469	Unknown		False	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs603424	SCD	10	102106881	myristate (14:0)/ myristoleate (14:1n5)	102124591	Metabolism, Environmental Information Processing, Organismal Systems	Lipid metabolism	True	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	True
rs603424	SGPL1	10	72575717	myristate (14:0)/ myristoleate (14:1n5)	72640930	Metabolism, Environmental Information Processing	Lipid metabolism	True	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs603424	PDCD11	10	105156405	myristate (14:0)/ myristoleate (14:1n5)	105206049	Unknown		False	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs603424	HK1	10	71029740	myristate (14:0)/ myristoleate (14:1n5)	71161638	Metabolism, Environmental Information Processing, Organismal Systems, Human Diseases	Biosynthesis of other secondary metabolites	True	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs603424	LIN52	14	74551499	myristate (14:0)/ myristoleate (14:1n5)	74667936	Cellular Processes		False	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs603424	CACUL1	10	120433679	myristate (14:0)/ myristoleate (14:1n5)	120514761	Unknown		False	85	SCD	stearoyl-CoA desaturase (delta-9-desaturase)	Cytoplasm	enzyme	myristate (14:0)/ myristoleate (14:1n5)	SCD encodes the stearyl-CoA desaturase which acts on medium chain-length acyl-CoAs to bring about the delta‐9‐desaturation of various fatty acids, such as the conversion of myristate (14:0) to myristoleate (14:1n5), palmitate (16:0) to palmitoleate (16:1n7) and stearate (18:0) to oleate (18:1n9) [8453]. Ratio interpretation: the molecules are the free fatty acid derivatives of the acyl-Coa forms of the substrate and product for SCD ('activity').	SCD	SCD-FAT	NA	myristate (14:0)/myristoleate (14:1n5) [21886157]; C14/C16:1 [20037589]; Palmitic acid (16:0) plasma levels [23362303]; Palmitoleic acid (16:1n-7) plasma levels [23362303]; Phospholipid levels (plasma) [22359512]	NA	NA	CHEMBL5555	Compounds with activity in ChEMBL	4	11	SCD FAT	True	SCD	False
rs6151429	ARSA	22	51061182	X-11423--O-sulfo-L-tyrosine	51066607	Metabolism, Cellular Processes	Lipid metabolism	True	145	ARSA	arylsulfatase A	Cytoplasm	enzyme	X-11423--O-sulfo-L-tyrosine	ARSA encodes the arylsulfatase A which can act on L-tyrosine O-sulfate [33715].  X-11423 has been identified as e O-sulfo-L-tyrosine.	ARSA	ARSA-FAT,ARSA-LCL,ARSA-Skin	NA	NA	Metachromatic leukodystrophy, adult form|Metachromatic leukodystrophy, juvenile form|Metachromatic leukodystrophy, late infantile form	ME	CHEMBL2193	No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL	2	2	ARSA FAT ARSA LCL ARSA Skin	True	ARSA	True
rs6151429	CABIN1	22	24407642	X-11423--O-sulfo-L-tyrosine	24574596	Unknown		False	145	ARSA	arylsulfatase A	Cytoplasm	enzyme	X-11423--O-sulfo-L-tyrosine	ARSA encodes the arylsulfatase A which can act on L-tyrosine O-sulfate [33715].  X-11423 has been identified as e O-sulfo-L-tyrosine.	ARSA	ARSA-FAT,ARSA-LCL,ARSA-Skin	NA	NA	Metachromatic leukodystrophy, adult form|Metachromatic leukodystrophy, juvenile form|Metachromatic leukodystrophy, late infantile form	ME	CHEMBL2193	No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL	2	2	ARSA FAT ARSA LCL ARSA Skin	True	ARSA	False
rs6430553	CCNT2	2	135675805	X-12095--N1-methyl-3-pyridone-4-carboxamide	135716912	Human Diseases		False	19	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide	ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, the key enzyme regulating de novo synthesis of NAD from tryptophan [16807375].  X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation [12694300]	ACMSD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ACMSD	False
rs6430553	AC016725.4	2	135493034	X-12095--N1-methyl-3-pyridone-4-carboxamide	135635213	Unknown		False	19	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide	ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, the key enzyme regulating de novo synthesis of NAD from tryptophan [16807375].  X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation [12694300]	ACMSD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ACMSD	False
rs6430553	TMEM163	2	135213330	X-12095--N1-methyl-3-pyridone-4-carboxamide	135476570	Unknown		False	19	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide	ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, the key enzyme regulating de novo synthesis of NAD from tryptophan [16807375].  X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation [12694300]	ACMSD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ACMSD	False
rs6430553	UBXN4	2	136499189	X-12095--N1-methyl-3-pyridone-4-carboxamide	136542625	Unknown		False	19	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide	ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, the key enzyme regulating de novo synthesis of NAD from tryptophan [16807375].  X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation [12694300]	ACMSD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ACMSD	False
rs6459467	GMPR	6	16238811	hypoxanthine	16295780	Metabolism	Nucleotide metabolism	True	48	GMPR	guanosine monophosphate reductase	Cytoplasm	enzyme	hypoxanthine	GMPR encodes guanosine monophosphate reducatase which converts guanosine monophosphate to inosine monophosphate which can subsequently be converted to hypoxanthine by the enzyme purine-nucleoside phosphorylase     [218932].	GMPR	NA	NA	Xanthosine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	GMPR	True
rs6459467	SLC16A10	6	111408781	hypoxanthine	111552397	Organismal Systems		False	48	GMPR	guanosine monophosphate reductase	Cytoplasm	enzyme	hypoxanthine	GMPR encodes guanosine monophosphate reducatase which converts guanosine monophosphate to inosine monophosphate which can subsequently be converted to hypoxanthine by the enzyme purine-nucleoside phosphorylase     [218932].	GMPR	NA	NA	Xanthosine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	GMPR	False
rs6459467	RNF182	6	13924677	hypoxanthine	13980533	Unknown		False	48	GMPR	guanosine monophosphate reductase	Cytoplasm	enzyme	hypoxanthine	GMPR encodes guanosine monophosphate reducatase which converts guanosine monophosphate to inosine monophosphate which can subsequently be converted to hypoxanthine by the enzyme purine-nucleoside phosphorylase     [218932].	GMPR	NA	NA	Xanthosine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	GMPR	False
rs6497490	ACSM5	16	20420856	X-11478	20452571	Metabolism	Carbohydrate metabolism	True	117	ACSM2A	acyl-CoA synthetase medium-chain family member 2A	Cytoplasm	enzyme	X-11478	X-11478 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs6678639	CYP4A11	1	47394849	10-undecenoate (11:1n1)/ X-11438	47407156	Metabolism, Organismal Systems	Metabolism of cofactors and vitamins	True	4	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	CYP4A11 encodes a fatty acid omega‐hydroxylase [8274222, 10860550] with documented activity on laurate (C12:0) and palmitate (C16:0).  X-11438 may be a hydroxylated tridecenoic acid (C13:1(OH)). Ratio interpretation: n/a.	CYP4A11	CYP4B1-Skin	NA	10-nonadecenoate (19:1n9)/10-undecenoate (11:1n1) [21886157]	NA	ME	CHEMBL3978	Presumed 10-undecenoic acid (CHEMBL1276010), an approved anti-fungal agent used to treat skin infections. No clear indication as to whether this enzyme is directly responsible for this transformation.	NA	NA	CYP4B1 Skin	False	CYP4A11	True
rs6678639	CYP4B1	1	47223510	10-undecenoate (11:1n1)/ X-11438	47285085	Unknown		False	4	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	CYP4A11 encodes a fatty acid omega‐hydroxylase [8274222, 10860550] with documented activity on laurate (C12:0) and palmitate (C16:0).  X-11438 may be a hydroxylated tridecenoic acid (C13:1(OH)). Ratio interpretation: n/a.	CYP4A11	CYP4B1-Skin	NA	10-nonadecenoate (19:1n9)/10-undecenoate (11:1n1) [21886157]	NA	ME	CHEMBL3978	Presumed 10-undecenoic acid (CHEMBL1276010), an approved anti-fungal agent used to treat skin infections. No clear indication as to whether this enzyme is directly responsible for this transformation.	NA	NA	CYP4B1 Skin	False	CYP4A11	False
rs6678639	BCL2	18	60790579	10-undecenoate (11:1n1)/ X-11438	60987361	Genetic Information Processing, Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	4	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11	Cytoplasm	enzyme	10-undecenoate (11:1n1)/ X-11438	CYP4A11 encodes a fatty acid omega‐hydroxylase [8274222, 10860550] with documented activity on laurate (C12:0) and palmitate (C16:0).  X-11438 may be a hydroxylated tridecenoic acid (C13:1(OH)). Ratio interpretation: n/a.	CYP4A11	CYP4B1-Skin	NA	10-nonadecenoate (19:1n9)/10-undecenoate (11:1n1) [21886157]	NA	ME	CHEMBL3978	Presumed 10-undecenoic acid (CHEMBL1276010), an approved anti-fungal agent used to treat skin infections. No clear indication as to whether this enzyme is directly responsible for this transformation.	NA	NA	CYP4B1 Skin	False	CYP4A11	False
rs6679002	DOCK7	1	62920399	X-03094	63153969	Unknown		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6679002	USP1	1	62901968	X-03094	62917475	Genetic Information Processing		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6679002	ATG4C	1	63249806	X-03094	63331184	Cellular Processes		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6679002	ANGPTL3	1	63063158	X-03094	63071830	Organismal Systems		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	True
rs6679002	FGD4	12	32552463	X-03094	32798984	Unknown		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6679002	CDC14A	1	100817290	X-03094	100985833	Cellular Processes		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6679002	CD8A	2	87011729	X-03094	87035519	Environmental Information Processing, Organismal Systems, Human Diseases		False	6	ANGPTL3	angiopoietin-like 3	Extracellular Space	growth factor	X-03094	ANGPTL3 regulates TG clearance by reducing the activity of LPL [22063269].  X-03094 is a GGM neighbor of cholesterol [23093944].	ANGPTL3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ANGPTL3	False
rs6693388	THEM4	1	151846060	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	151882284	Metabolism, Environmental Information Processing	Lipid metabolism	True	11	THEM4	thioesterase superfamily member 4	Plasma Membrane	enzyme	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	THEM4 is a broad range acyl-CoA thioesterase with a preference for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified as 5,8-tetradecadienoate. Ratio interpretation: both molecules are potential products of THEM4 ('selectivity').	THEM4	THEM4-FAT,THEM4-LCL,THEM4-Skin,LINGO4-Skin,S100A10-LIVER,S100A10-LCL	NA	NA	NA	NA	NA	NA	NA	NA	THEM4 FAT THEM4 LCL THEM4 Skin LINGO4 Skin S100A10 LIVER S100A10 LCL	True	THEM4	True
rs6693388	S100A10	1	151955391	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	151966866	Unknown		False	11	THEM4	thioesterase superfamily member 4	Plasma Membrane	enzyme	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	THEM4 is a broad range acyl-CoA thioesterase with a preference for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified as 5,8-tetradecadienoate. Ratio interpretation: both molecules are potential products of THEM4 ('selectivity').	THEM4	THEM4-FAT,THEM4-LCL,THEM4-Skin,LINGO4-Skin,S100A10-LIVER,S100A10-LCL	NA	NA	NA	NA	NA	NA	NA	NA	THEM4 FAT THEM4 LCL THEM4 Skin LINGO4 Skin S100A10 LIVER S100A10 LCL	True	THEM4	False
rs6693388	NBPF18P	1	151967007	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	152015250	Unknown		False	11	THEM4	thioesterase superfamily member 4	Plasma Membrane	enzyme	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	THEM4 is a broad range acyl-CoA thioesterase with a preference for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified as 5,8-tetradecadienoate. Ratio interpretation: both molecules are potential products of THEM4 ('selectivity').	THEM4	THEM4-FAT,THEM4-LCL,THEM4-Skin,LINGO4-Skin,S100A10-LIVER,S100A10-LCL	NA	NA	NA	NA	NA	NA	NA	NA	THEM4 FAT THEM4 LCL THEM4 Skin LINGO4 Skin S100A10 LIVER S100A10 LCL	True	THEM4	False
rs6693388	S100A11	1	152004982	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	152020383	Unknown		False	11	THEM4	thioesterase superfamily member 4	Plasma Membrane	enzyme	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	THEM4 is a broad range acyl-CoA thioesterase with a preference for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified as 5,8-tetradecadienoate. Ratio interpretation: both molecules are potential products of THEM4 ('selectivity').	THEM4	THEM4-FAT,THEM4-LCL,THEM4-Skin,LINGO4-Skin,S100A10-LIVER,S100A10-LCL	NA	NA	NA	NA	NA	NA	NA	NA	THEM4 FAT THEM4 LCL THEM4 Skin LINGO4 Skin S100A10 LIVER S100A10 LCL	True	THEM4	False
rs6693388	KRT8P28	1	151921999	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	151923388	Unknown		False	11	THEM4	thioesterase superfamily member 4	Plasma Membrane	enzyme	linoleate (18:2n6)/ X-12442--5,8-tetradecadienoate	THEM4 is a broad range acyl-CoA thioesterase with a preference for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified as 5,8-tetradecadienoate. Ratio interpretation: both molecules are potential products of THEM4 ('selectivity').	THEM4	THEM4-FAT,THEM4-LCL,THEM4-Skin,LINGO4-Skin,S100A10-LIVER,S100A10-LCL	NA	NA	NA	NA	NA	NA	NA	NA	THEM4 FAT THEM4 LCL THEM4 Skin LINGO4 Skin S100A10 LIVER S100A10 LCL	True	THEM4	False
rs6804368	GADL1	3	30767692	X-12244--N-acetylcarnosine	30936257	Metabolism	Metabolism of cofactors and vitamins	True	25	GADL1	glutamate decarboxylase-like 1	unknown	enzyme	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs6804368	RP11-102	3	30739153	X-12244--N-acetylcarnosine	30741068	Unknown		False	25	GADL1	glutamate decarboxylase-like 1	unknown	enzyme	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs6968554	AC003075.4	7	17319458	caffeine	17338981	Unknown		False	57	AHR	aryl hydrocarbon receptor	Nucleus	ligand-dependent nuclear receptor	caffeine	"AHR encodes the aromatic hydrocarbon receptor, a transcription factor which activates CYP1A1 and CYP1A2 [10605936].  These enzymes metabolize caffeine [8095225]
"	AHR	NA	Caffeine consumption [21490707]; Coffee consumption [21357676]	caffeine/quinate [21886157] (r2=0.669 with rs12670403)	NA	ME	CHEMBL3201	Substrates: Flutamide, Dantrolene, PAHs, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (other PHAHs), β-naphthoflavone, indigoids, tryptophan metabolites, omeprazole, lansoprazole; Inhibitors: CH-223191, α-naphthoflavon, omerprazole sulfide	2	3	NA	False	AHR	False
rs6968554	GRID2IP	7	6537093	caffeine	6591067	Unknown		False	57	AHR	aryl hydrocarbon receptor	Nucleus	ligand-dependent nuclear receptor	caffeine	"AHR encodes the aromatic hydrocarbon receptor, a transcription factor which activates CYP1A1 and CYP1A2 [10605936].  These enzymes metabolize caffeine [8095225]
"	AHR	NA	Caffeine consumption [21490707]; Coffee consumption [21357676]	caffeine/quinate [21886157] (r2=0.669 with rs12670403)	NA	ME	CHEMBL3201	Substrates: Flutamide, Dantrolene, PAHs, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (other PHAHs), β-naphthoflavone, indigoids, tryptophan metabolites, omeprazole, lansoprazole; Inhibitors: CH-223191, α-naphthoflavon, omerprazole sulfide	2	3	NA	False	AHR	False
rs6980334	MAGI2	7	77646393	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	79082890	Environmental Information Processing		False	63	AKR1D1	aldo-keto reductase family 1, member D1	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	AKR1D1 encodes an NADPH-dependent delta 4-3-ketosteroid-5-beta-reductase, which catalyzes 5-beta-reduction of certain steroid molecules [7508385]. X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation. Ratio interpretation: n/a.	AKR1D1	NA	NA	NA	Congenital bile acid synthesis defect type 2	ME	NA	Azelaic acid seems to inhibit this protein (PMID: 3207614)	NA	NA	NA	False	AKR1D1	False
rs6980334	IMMP2L	7	110303110	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	111202573	Genetic Information Processing		False	63	AKR1D1	aldo-keto reductase family 1, member D1	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	AKR1D1 encodes an NADPH-dependent delta 4-3-ketosteroid-5-beta-reductase, which catalyzes 5-beta-reduction of certain steroid molecules [7508385]. X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation. Ratio interpretation: n/a.	AKR1D1	NA	NA	NA	Congenital bile acid synthesis defect type 2	ME	NA	Azelaic acid seems to inhibit this protein (PMID: 3207614)	NA	NA	NA	False	AKR1D1	False
rs6980334	MTPN	7	135611509	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	135662101	Unknown		False	63	AKR1D1	aldo-keto reductase family 1, member D1	Cytoplasm	enzyme	X-12095--N1-methyl-3-pyridone-4-carboxamide/ X-12844	AKR1D1 encodes an NADPH-dependent delta 4-3-ketosteroid-5-beta-reductase, which catalyzes 5-beta-reduction of certain steroid molecules [7508385]. X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation. Ratio interpretation: n/a.	AKR1D1	NA	NA	NA	Congenital bile acid synthesis defect type 2	ME	NA	Azelaic acid seems to inhibit this protein (PMID: 3207614)	NA	NA	NA	False	AKR1D1	False
rs7061710	FMO3	1	171060018	X-11786--methylcysteine	171086959	Metabolism	Xenobiotics biodegradation and metabolism	True	13	FMO3	flavin containing monooxygenase 3	Cytoplasm	enzyme	X-11786--methylcysteine	FMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.	FMO3	FMO3-FAT,FMO3-Skin,FMO2-FAT,FMO2-Skin	NA	NA	NA	ME	NA	Substrate: chlorpromazine, trimethylamine, cimetidine	NA	NA	FMO3 FAT FMO3 Skin FMO2 FAT FMO2 Skin	True	FMO3	True
rs7061710	FMO6P	1	171106879	X-11786--methylcysteine	171130707	Unknown		False	13	FMO3	flavin containing monooxygenase 3	Cytoplasm	enzyme	X-11786--methylcysteine	FMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.	FMO3	FMO3-FAT,FMO3-Skin,FMO2-FAT,FMO2-Skin	NA	NA	NA	ME	NA	Substrate: chlorpromazine, trimethylamine, cimetidine	NA	NA	FMO3 FAT FMO3 Skin FMO2 FAT FMO2 Skin	True	FMO3	False
rs7061710	FMO2	1	171154347	X-11786--methylcysteine	171181822	Metabolism	Xenobiotics biodegradation and metabolism	True	13	FMO3	flavin containing monooxygenase 3	Cytoplasm	enzyme	X-11786--methylcysteine	FMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.	FMO3	FMO3-FAT,FMO3-Skin,FMO2-FAT,FMO2-Skin	NA	NA	NA	ME	NA	Substrate: chlorpromazine, trimethylamine, cimetidine	NA	NA	FMO3 FAT FMO3 Skin FMO2 FAT FMO2 Skin	True	FMO3	False
rs7061710	DNAH14	1	225083964	X-11786--methylcysteine	225586996	Unknown		False	13	FMO3	flavin containing monooxygenase 3	Cytoplasm	enzyme	X-11786--methylcysteine	FMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.	FMO3	FMO3-FAT,FMO3-Skin,FMO2-FAT,FMO2-Skin	NA	NA	NA	ME	NA	Substrate: chlorpromazine, trimethylamine, cimetidine	NA	NA	FMO3 FAT FMO3 Skin FMO2 FAT FMO2 Skin	True	FMO3	False
rs7061710	ASTN1	1	176826438	X-11786--methylcysteine	177134109	Unknown		False	13	FMO3	flavin containing monooxygenase 3	Cytoplasm	enzyme	X-11786--methylcysteine	FMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.	FMO3	FMO3-FAT,FMO3-Skin,FMO2-FAT,FMO2-Skin	NA	NA	NA	ME	NA	Substrate: chlorpromazine, trimethylamine, cimetidine	NA	NA	FMO3 FAT FMO3 Skin FMO2 FAT FMO2 Skin	True	FMO3	False
rs7157785	NUMB	14	73741815	X-08402/ cholesterol	73930197	Environmental Information Processing		False	103	SGPP1	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	Plasma Membrane	transporter	X-08402/ cholesterol	SGPP1 encodes a  lipid phosphatase that dephosphorylates sphingosine-1-phosphate to sphingosine.  [10859351].   In other GWAS, this locus has been associated with levels of different sphingomyelin species [22359512]. Ratio interpretation: n/a.	SGPP1	NA	Sphingolipid levels [22359512,19798445]	PC ae C38:1/PC aa C28:1 [20037589] (r2=0.732 with rs11158519); SM 14:0 [23823483]	NA	NA	NA	NA	NA	NA	NA	False	SGPP1	False
rs7542172	MKNK1	1	47023090	erythritol	47069966	Environmental Information Processing, Organismal Systems		False	3	DMBX1	diencephalon/mesencephalon homeobox 1	Nucleus	transcription regulator	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7542172	EFCAB14	1	47140831	erythritol	47184824	Unknown		False	3	DMBX1	diencephalon/mesencephalon homeobox 1	Nucleus	transcription regulator	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7542172	MOB3C	1	47073387	erythritol	47082563	Unknown		False	3	DMBX1	diencephalon/mesencephalon homeobox 1	Nucleus	transcription regulator	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7542172	FGR	1	27938575	erythritol	27961788	Organismal Systems		False	3	DMBX1	diencephalon/mesencephalon homeobox 1	Nucleus	transcription regulator	erythritol	Erythritol ((2R,3S)-butane-1,2,3,4-tetraol) is a sugar alcohol (or polyol) that has been approved for use as a food additive in the United States. It occurs naturally in some fruits and fermented food; less calories than regular sugar, no major side effects reported.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	CCNT2	2	135675805	1,5-anhydroglucitol (1,5-AG)	135716912	Human Diseases		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	MCM6	2	136597196	1,5-anhydroglucitol (1,5-AG)	136633996	Genetic Information Processing, Cellular Processes		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	AC093391.2	2	136742746	1,5-anhydroglucitol (1,5-AG)	136779888	Unknown		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	TMEM163	2	135213330	1,5-anhydroglucitol (1,5-AG)	135476570	Unknown		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	DARS	2	136664247	1,5-anhydroglucitol (1,5-AG)	136743447	Genetic Information Processing		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	UBXN4	2	136499189	1,5-anhydroglucitol (1,5-AG)	136542625	Unknown		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	MAP3K19	2	135722061	1,5-anhydroglucitol (1,5-AG)	135805028	Unknown		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7570971	SAP130	2	128698791	1,5-anhydroglucitol (1,5-AG)	128785694	Unknown		False	20	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)	Cytoplasm	other	1,5-anhydroglucitol (1,5-AG)	1,5-anhydroglucitol (1,5-AG) is a marker for glycemic control [21085649]	unknown	NA	Cholesterol, total [20686565]	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7642243	SLC51A	3	195938358	X-09789	195970049	Organismal Systems		False	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7642243	MUC4	3	195473636	X-09789	195539148	Unknown		False	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7642243	ZDHHC19	3	195924320	X-09789	195938308	Unknown		False	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7642243	TM4SF19	3	196046213	X-09789	196065374	Unknown		False	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7642243	TNK2	3	195590235	X-09789	195638816	Unknown		False	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7642243	PCYT1A	3	195941093	X-09789	196014828	Metabolism, Human Diseases	Amino acid metabolism	True	32	SLC51A	solute carrier family 51, alpha subunit	Plasma Membrane	transporter	X-09789	X-09789 is an unknown metabolite	unknown	NA	NA	NA	NA	NA	CHEMBL2073724	Dinoprostone, digoxin, and estrone sulfuric with activity in ChEMBL	NA	NA	NA	False	unknown	False
rs7775554	SRSF12	6	89805678	X-12244--N-acetylcarnosine	89827800	Unknown		False	53	PM20D2	peptidase M20 domain containing 2	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7775554	PM20D2	6	89855769	X-12244--N-acetylcarnosine	89875284	Unknown		False	53	PM20D2	peptidase M20 domain containing 2	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7775554	PNRC1	6	89790470	X-12244--N-acetylcarnosine	89794879	Unknown		False	53	PM20D2	peptidase M20 domain containing 2	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7775554	DOPEY1	6	83777385	X-12244--N-acetylcarnosine	83881069	Unknown		False	53	PM20D2	peptidase M20 domain containing 2	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs7809615	CNPY4	7	99717236	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99723134	Unknown		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	ZKSCAN5	7	99102274	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99132323	Unknown		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	GS1-259H	7	99195689	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99208439	Unknown		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	CYP3A7	7	99302667	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99332719	Metabolism, Human Diseases	Metabolism of cofactors and vitamins	True	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	CPSF4	7	99036545	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99054994	Genetic Information Processing, Human Diseases		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	CYP3A5	7	99245817	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99277621	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	True
rs7809615	TAF6	7	99707571	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99717190	Genetic Information Processing		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	PTCD1	7	99014362	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	99036539	Unknown		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	ARPC1B	7	98971872	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	98992424	Cellular Processes, Organismal Systems, Human Diseases		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	ARPC1A	7	98923521	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	98963880	Cellular Processes, Organismal Systems, Human Diseases		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	AVL9	7	32535038	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	33078516	Unknown		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7809615	NRG4	15	76228310	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	76352136	Environmental Information Processing		False	60	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5	Cytoplasm	enzyme	androsterone sulfate/ 4-androsten-3beta,17beta-diol disulfate 2	CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including  testosterone and progesterone.   [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity').	CYP3A5	CPSF4-LCL	NA	androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175]	NA	ME	CHEMBL3019	Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa	NA	NA	CPSF4 LCL	False	CYP3A5	False
rs7849270	PPP2R4	9	131873229	C-glycosyltryptophan/ succinylcarnitine	131911225	Unknown		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	CRAT	9	131857089	C-glycosyltryptophan/ succinylcarnitine	131873468	Cellular Processes		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	True
rs7849270	RP11-247	9	131963594	C-glycosyltryptophan/ succinylcarnitine	131972827	Unknown		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	DOLPP1	9	131843379	C-glycosyltryptophan/ succinylcarnitine	131852717	Metabolism	Carbohydrate metabolism	True	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	TOR1A	9	132575223	C-glycosyltryptophan/ succinylcarnitine	132586413	Unknown		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	SH3GLB2	9	131769376	C-glycosyltryptophan/ succinylcarnitine	131790582	Cellular Processes		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	RP11-247	9	131860133	C-glycosyltryptophan/ succinylcarnitine	131862545	Unknown		False	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7849270	FPGS	9	130556876	C-glycosyltryptophan/ succinylcarnitine	130576606	Metabolism, Human Diseases	Metabolism of cofactors and vitamins	True	73	CRAT	carnitine O-acetyltransferase	Cytoplasm	enzyme	C-glycosyltryptophan/ succinylcarnitine	"CRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives.  CRAT has maximal activity for propionyl-CoA [2351134].  Ratio interpretation: n/a.
"	CRAT	CRAT-LCL,ENDOG-LCL,IER5L-LCL,PPP2R4-FAT,PPP2R4-Skin	NA	NA	NA	NA	CHEMBL3184	Compounds with no inhibitory activity in ChEMBL	NA	1	CRAT LCL ENDOG LCL IER5L LCL PPP2R4 FAT PPP2R4 Skin	True	CRAT	False
rs7969761	CCDC77	12	498621	betaine/ pyroglutamine	551811	Unknown		False	93	SLC6A13	solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	Plasma Membrane	transporter	betaine/ pyroglutamine	SLC6A13 encodes GAT2 which transports betaine in addition to GABA [8420981]. Ratio interpretation: n/a.	SLC6A13	NA	Chronic kidney disease [20383146]	NA	NA	NA	CHEMBL4535	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A13	False
rs7969761	SLC6A13	12	329789	betaine/ pyroglutamine	372039	Organismal Systems		False	93	SLC6A13	solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	Plasma Membrane	transporter	betaine/ pyroglutamine	SLC6A13 encodes GAT2 which transports betaine in addition to GABA [8420981]. Ratio interpretation: n/a.	SLC6A13	NA	Chronic kidney disease [20383146]	NA	NA	NA	CHEMBL4535	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A13	True
rs7969761	KDM5A	12	389295	betaine/ pyroglutamine	498438	Unknown		False	93	SLC6A13	solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	Plasma Membrane	transporter	betaine/ pyroglutamine	SLC6A13 encodes GAT2 which transports betaine in addition to GABA [8420981]. Ratio interpretation: n/a.	SLC6A13	NA	Chronic kidney disease [20383146]	NA	NA	NA	CHEMBL4535	Compounds with inhibitory activity in ChEMBL	NA	NA	NA	False	SLC6A13	False
rs8002180	ABCC4	13	95672083	X-12244--N-acetylcarnosine	95953687	Environmental Information Processing, Organismal Systems, Human Diseases		False	101	ABCC4	WD repeat domain 66	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	TP	CHEMBL1743128	Substrates: Adefovir, tenofovir, cyclic AMP, dehydroepian- drosterone sulphate, methotrexate, topotecan, furosemide, cyclic GMP, bile acids plus glutathione. Inhibitors: Celecoxib, diclofenac (PMID: 20190787)	NA	NA	NA	False	unknown	False
rs8002180	FGF14	13	102372134	X-12244--N-acetylcarnosine	103054124	Unknown		False	101	ABCC4	WD repeat domain 66	unknown	other	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	TP	CHEMBL1743128	Substrates: Adefovir, tenofovir, cyclic AMP, dehydroepian- drosterone sulphate, methotrexate, topotecan, furosemide, cyclic GMP, bile acids plus glutathione. Inhibitors: Celecoxib, diclofenac (PMID: 20190787)	NA	NA	NA	False	unknown	False
rs8012	SYCE2	19	13009600	glutaroyl carnitine	13030090	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	FARSA	19	13033293	glutaroyl carnitine	13044851	Genetic Information Processing		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	GCDH	19	13001840	glutaroyl carnitine	13025021	Metabolism	Amino acid metabolism	True	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	True
rs8012	CALR	19	13049421	glutaroyl carnitine	13055303	Genetic Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	PRDX2	19	12907634	glutaroyl carnitine	12912694	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	AD000092.3	19	13004947	glutaroyl carnitine	13005694	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	HOOK2	19	12873817	glutaroyl carnitine	12983554	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	RTBDN	19	12936292	glutaroyl carnitine	12946242	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	CTD-2265	19	12937686	glutaroyl carnitine	12943797	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	DNASE2	19	12986025	glutaroyl carnitine	12992282	Cellular Processes		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	CTD-2192	19	12640582	glutaroyl carnitine	12643787	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	WDR83OS	19	12778885	glutaroyl carnitine	12782170	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	ASF1B	19	14230350	glutaroyl carnitine	14247768	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	RFX1	19	14072350	glutaroyl carnitine	14117851	Unknown		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	SMARCB1	22	24129150	glutaroyl carnitine	24176689	Organismal Systems, Human Diseases		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8012	SYMPK	19	46318668	glutaroyl carnitine	46366548	Genetic Information Processing, Cellular Processes		False	132	GCDH	glutaryl-CoA dehydrogenase	Cytoplasm	enzyme	glutaroyl carnitine	GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514].  Acyl-carnitines and acyl-CoAs readily interconvert	GCDH	GCDH-FAT,GCDH-LCL,GCDH-Skin	NA	NA	Glutaric acidemia type 1.	NA	NA	NA	NA	NA	GCDH FAT GCDH LCL GCDH Skin	True	GCDH	False
rs8018967	ACOT1	14	74003818	X-13215/ X-13671	74010498	Metabolism	Lipid metabolism	True	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	HEATR4	14	73945189	X-13215/ X-13671	74025651	Unknown		False	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	VSX2	14	74706175	X-13215/ X-13671	74729441	Unknown		False	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	ACOT2	14	74034324	X-13215/ X-13671	74042357	Metabolism, Organismal Systems	Lipid metabolism	True	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	RP3-414A	14	73983937	X-13215/ X-13671	73987352	Unknown		False	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	ACTN1	14	69340860	X-13215/ X-13671	69446157	Cellular Processes, Organismal Systems, Human Diseases		False	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8018967	VMP1	17	57784553	X-13215/ X-13671	57918453	Cellular Processes		False	104	HEATR4	sphingosine-1-phosphate phosphatase 1	Cytoplasm	phosphatase	X-13215/ X-13671	X-13671 is an unknown metabolite. Ratio interpretation: n/a.	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs8051149	SLC7A5	16	87863629	kynurenine	87903094	Environmental Information Processing, Human Diseases		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	True
rs8051149	RP4-536B	16	87870254	kynurenine	87871269	Unknown		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	False
rs8051149	ABCC1	16	16043434	kynurenine	16236931	Environmental Information Processing, Organismal Systems, Human Diseases		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	False
rs8051149	STRADA	17	61780192	kynurenine	61819330	Environmental Information Processing		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	False
rs8051149	CDH1	16	68771128	kynurenine	68869451	Environmental Information Processing, Cellular Processes, Human Diseases		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	False
rs8051149	CLEC16A	16	11038345	kynurenine	11276046	Unknown		False	124	SLC7A5	solute carrier family 7 (amino acid transporter light chain, L system), member 5	Plasma Membrane	transporter	kynurenine	SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange [17896864]	SLC7A5	SLC7A5-FAT,SLC7A5-Skin	NA	NA	NA	TP	CHEMBL4459	No specific drug is associated with this transporter; compounds and approved drugs with low activity in ChEMBL	1	4	SLC7A5 FAT SLC7A5 Skin	True	SLC7A5	False
rs8056893	PRMT7	16	68344877	lysine/ glutaroyl carnitine	68392230	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	NFATC3	16	68118654	lysine/ glutaroyl carnitine	68255187	Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	PLA2G15	16	68279207	lysine/ glutaroyl carnitine	68294961	Metabolism, Cellular Processes	Lipid metabolism	True	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	SMPD3	16	68392457	lysine/ glutaroyl carnitine	68482591	Metabolism	Lipid metabolism	True	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	SLC7A6	16	68298433	lysine/ glutaroyl carnitine	68335722	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	True
rs8056893	NRN1L	16	67918708	lysine/ glutaroyl carnitine	67922758	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	ZFP90	16	68563993	lysine/ glutaroyl carnitine	68609975	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	CES4A	16	67022492	lysine/ glutaroyl carnitine	67043661	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	CMIP	16	81478775	lysine/ glutaroyl carnitine	81745367	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8056893	ZNF317	19	9251056	lysine/ glutaroyl carnitine	9274100	Unknown		False	123	SLC7A6	solute carrier family 7 (amino acid transporter light chain, y+L system), member 6	Plasma Membrane	transporter	lysine/ glutaroyl carnitine	SLC7A6 encodes the y+LAT-2 amino acid transporter, which has several amino acid substrates, including lysine [10903140].  Glutaryl‐CoA is an intermediate in the metabolism of lysine and tryptophan [16602100]. Ratio interpretation: n/a,	SLC7A6	PLA2G15-FAT,PLA2G15-LCL,PLA2G15-Skin,ZFP90-LCL	NA	glutaroyl carnitine/lysine [21886157]	NA	NA	NA	NA	NA	NA	PLA2G15 FAT PLA2G15 LCL PLA2G15 Skin ZFP90 LCL	False	SLC7A6	False
rs8101881	CEP89	19	33369902	homocitrulline	33462897	Unknown		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	False
rs8101881	SLC7A9	19	33321415	homocitrulline	33360672	Organismal Systems		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	True
rs8101881	NUDT19	19	33182867	homocitrulline	33204702	Cellular Processes		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	False
rs8101881	C19orf40	19	33463115	homocitrulline	33469128	Unknown		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	False
rs8101881	PDCD5	19	33071974	homocitrulline	33078358	Unknown		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	False
rs8101881	TDRD12	19	33210659	homocitrulline	33320483	Unknown		False	134	SLC7A9	solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9	Plasma Membrane	transporter	homocitrulline	SLC7A9 associates with urine levels of lysine [21572414].  Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607]	SLC7A9	SLC7A9-FAT,SLC7A9-Skin	Chronic kidney disease [20383146]	Urinary metabolites [21572414]	Cystinuria type B	NA	NA	NA	NA	NA	SLC7A9 FAT SLC7A9 Skin	True	SLC7A9	False
rs835154	ANKH	5	14704910	citrate	14871887	Unknown		False	40	ANKH	ankylosis, progressive homolog (mouse)	Plasma Membrane	transporter	citrate	Citrate is a Krebs cycle intermediate	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs835154	CACNA1C	12	2079952	citrate	2802108	Environmental Information Processing, Organismal Systems, Human Diseases		False	40	ANKH	ankylosis, progressive homolog (mouse)	Plasma Membrane	transporter	citrate	Citrate is a Krebs cycle intermediate	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	unknown	False
rs887829	UGT1A6	2	234601512	biliverdin	234664997	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs887829	UGT1A7	2	234591014	biliverdin	234600993	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs887829	UGT1A1	2	234526291	biliverdin	234681956	Metabolism, Human Diseases	Xenobiotics biodegradation and metabolism	True	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	True
rs887829	UGT1A2P	2	234655860	biliverdin	234656725	Unknown		False	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs887829	RPL17P11	2	234630168	biliverdin	234630711	Unknown		False	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs887829	USP40	2	234384166	biliverdin	234475428	Unknown		False	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs887829	AGAP1	2	236402733	biliverdin	237040444	Cellular Processes		False	23	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1	Cytoplasm	enzyme	biliverdin	UGT1A1 encodes an enzyme with bilirubin glucuronidating activity [1898728].  Bilirubin is derived from biliverdin.	UGT1A1	NA	Bilirubin levels [21646302,23371916,19419973,22085899,19414484]; Cholelithiasis-related traits in sickle cell anemia [22558097]; Circulating cell-free DNA [22511988];	bilirubin (E,E)*/oleoylcarnitine [21886157]; X-11530,X-11441,X-11793,X-11442 [23093944]; Xanthurenate [23823483]	Crigler-Najjar syndrome (CNS); Gilbert's syndrome	ME	CHEMBL1287617	Substrate: Irinotecan is a topoisomerase I inhibitor used primarily to treat colorectal cancer. The UGT1A1*28 allele has been associated to toxicity.	NA	NA	NA	False	UGT1A1	False
rs9302065	DNAJC3-AS1	13	96300987	X-12244--N-acetylcarnosine	96329179	Unknown		False	102	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	Plasma Membrane	transporter	X-12244--N-acetylcarnosine	X-12244 has been identified as N-acetylcarnosine	unknown	NA	NA	NA	NA	TP	CHEMBL1743128	Substrates: Adefovir, tenofovir, cyclic AMP, dehydroepian- drosterone sulphate, methotrexate, topotecan, furosemide, cyclic GMP, bile acids plus glutathione. Inhibitors: Celecoxib, diclofenac (PMID: 20190787)	NA	NA	NA	False	unknown	False
rs938554	SLC2A9	4	9772777	urate	10056560	Unknown		False	33	SLC2A9	solute carrier family 2 (facilitated glucose transporter), member 9	Plasma Membrane	transporter	urate	SLC2A9 (GLUT9) encodes a transporter which acts on urate [18327257]. Ratio interpretation for urate/histidine: some evidence that histidine contributes to the urate pool, so histidine may serve to normalize urate levels in plasma ('normalizing') [4462579]	SLC2A9	NA	Uric acid levels [18759275,19503597];	Urate [18327256,18834626,18179892, 21886157]	NA	NA	CHEMBL2052034	Compounds with low inhibitory activity in ChEMBL	NA	NA	NA	False	SLC2A9	True
rs938554	MSANTD1	4	3246096	urate	3273465	Unknown		False	33	SLC2A9	solute carrier family 2 (facilitated glucose transporter), member 9	Plasma Membrane	transporter	urate	SLC2A9 (GLUT9) encodes a transporter which acts on urate [18327257]. Ratio interpretation for urate/histidine: some evidence that histidine contributes to the urate pool, so histidine may serve to normalize urate levels in plasma ('normalizing') [4462579]	SLC2A9	NA	Uric acid levels [18759275,19503597];	Urate [18327256,18834626,18179892, 21886157]	NA	NA	CHEMBL2052034	Compounds with low inhibitory activity in ChEMBL	NA	NA	NA	False	SLC2A9	False
rs9392556	ECI2	6	4115923	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	4135831	Metabolism, Cellular Processes	Lipid metabolism	True	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	True
rs9392556	C6orf201	6	4079456	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	4131185	Unknown		False	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	False
rs9392556	FAM217A	6	4049668	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	4087578	Unknown		False	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	False
rs9392556	RP3-400B	6	4145771	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	4146287	Unknown		False	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	False
rs9392556	PNPT1	2	55861400	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	55921045	Genetic Information Processing		False	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	False
rs9392556	SUPT3H	6	44777054	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	45345690	Human Diseases		False	46	ECI2	enoyl-CoA delta isomerase 2	Cytoplasm	enzyme	X-13435 (neutral acc mass: 313.225270 +/- 0.000910; similar to X-11421/4-decenoylcarnitine, but elutes later; prob a 10:1 carnitine)	ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to act on octenoyl-CoA [10419495] and could possibly act on decenoyl-CoA as well X-13435 is most probably a 10:1 carnitine.	ECI2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	False	ECI2	False
rs9393915	ELOVL2-AS1	6	11043757	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	11078459	Unknown		False	47	ELOVL2	ELOVL fatty acid elongase 2	Cytoplasm	enzyme	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	ELOVL2 encodes a long chain fatty acid elongase.  The coenzyme A derivative of DPA (22:5n3) is both a product and a substrate for the enzyme [12371743]. Ratio interpretation: n/a.	ELOVL2	NA	NA	Phospholipid levels (plasma) [22359512]; docosahexaenoate (DHA; 22:6n3)/eicosapentaenoate (EPA; 20:5n3) [21886157]; PC aa C40:3/PC aa C42:5 [20037589];	NA	NA	CHEMBL5911	Compounds with no activity in ChEMBL	NA	NA	NA	False	ELOVL2	True
rs9393915	SYCP2L	6	10887064	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	10979553	Unknown		False	47	ELOVL2	ELOVL fatty acid elongase 2	Cytoplasm	enzyme	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	ELOVL2 encodes a long chain fatty acid elongase.  The coenzyme A derivative of DPA (22:5n3) is both a product and a substrate for the enzyme [12371743]. Ratio interpretation: n/a.	ELOVL2	NA	NA	Phospholipid levels (plasma) [22359512]; docosahexaenoate (DHA; 22:6n3)/eicosapentaenoate (EPA; 20:5n3) [21886157]; PC aa C40:3/PC aa C42:5 [20037589];	NA	NA	CHEMBL5911	Compounds with no activity in ChEMBL	NA	NA	NA	False	ELOVL2	False
rs9393915	EEF1E1	6	8073593	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	8102811	Unknown		False	47	ELOVL2	ELOVL fatty acid elongase 2	Cytoplasm	enzyme	docosapentaenoate (n3 DPA; 22:5n3)/ X-12627	ELOVL2 encodes a long chain fatty acid elongase.  The coenzyme A derivative of DPA (22:5n3) is both a product and a substrate for the enzyme [12371743]. Ratio interpretation: n/a.	ELOVL2	NA	NA	Phospholipid levels (plasma) [22359512]; docosahexaenoate (DHA; 22:6n3)/eicosapentaenoate (EPA; 20:5n3) [21886157]; PC aa C40:3/PC aa C42:5 [20037589];	NA	NA	CHEMBL5911	Compounds with no activity in ChEMBL	NA	NA	NA	False	ELOVL2	False
rs9400467	REV3L	6	111620234	tyrosine	111804432	Genetic Information Processing, Human Diseases		False	54	SLC16A10	solute carrier family 16, member 10 (aromatic amino acid transporter)	Plasma Membrane	transporter	tyrosine	SLC16A10 encodes the T‐type amino acid transporter‐1 (TAT1); this transporter transports tryptophan, tyrosine and phenylalanine [11827462]	SLC16A10	NA	NA	isoleucine/tyrosine [21886157] (r2=0.333 with rs7760535); Tyrosine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	SLC16A10	False
rs9400467	KIAA1919	6	111580551	tyrosine	111592370	Unknown		False	54	SLC16A10	solute carrier family 16, member 10 (aromatic amino acid transporter)	Plasma Membrane	transporter	tyrosine	SLC16A10 encodes the T‐type amino acid transporter‐1 (TAT1); this transporter transports tryptophan, tyrosine and phenylalanine [11827462]	SLC16A10	NA	NA	isoleucine/tyrosine [21886157] (r2=0.333 with rs7760535); Tyrosine [23823483]	NA	NA	NA	NA	NA	NA	NA	False	SLC16A10	False
rs9635324	DISP2	15	40650436	propionylcarnitine/ isovalerylcarnitine	40663257	Unknown		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
rs9635324	IVD	15	40697686	propionylcarnitine/ isovalerylcarnitine	40728146	Metabolism	Amino acid metabolism	True	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	True
rs9635324	KNSTRN	15	40674922	propionylcarnitine/ isovalerylcarnitine	40686447	Unknown		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
rs9635324	BAHD1	15	40731920	propionylcarnitine/ isovalerylcarnitine	40760441	Unknown		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
rs9635324	RP11-111	15	40780240	propionylcarnitine/ isovalerylcarnitine	40850183	Unknown		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
rs9635324	MYO5A	15	52599480	propionylcarnitine/ isovalerylcarnitine	52821247	Unknown		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
rs9635324	ADAM10	15	58887403	propionylcarnitine/ isovalerylcarnitine	59042177	Human Diseases		False	106	IVD	asparaginase homolog (S. cerevisiae)	unknown	enzyme	propionylcarnitine/ isovalerylcarnitine	IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357].   Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation:  IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing')	IVD	IVD-FAT,IVD-LCL,IVD-Skin,DISP2-FAT,DISP2-Skin	NA	3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157]	Isovaleric acidemia	NA	NA	NA	NA	NA	IVD FAT IVD LCL IVD Skin DISP2 FAT DISP2 Skin	True	IVD	False
